TNMTumorClassificatie-v1.0(2020NL): verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
(Nieuwe pagina aangemaakt met '<!-- Hieronder wordt een transclude page aangeroepen --> {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.4.27(NL)|1|TNMTumorClassificatie-v1.0(2020NL)}} <!-- Tot hi...')
 
 
(19 tussenliggende versies door 3 gebruikers niet weergegeven)
Regel 117: Regel 117:
</imagemap>
</imagemap>
<imagemap> Bestand:PrimaireTumor-v1.0Model(2020NL).png | center  
<imagemap> Bestand:PrimaireTumor-v1.0Model(2020NL).png | center  
rect 670 351 836 387 [[#aT_PrimaireTumorCodelijst]]
rect 670 344 836 380 [[#aT_PrimaireTumorCodelijst]]
rect 670 303 836 339 [[#rpT_PrimaireTumorCodelijst]]
rect 670 295 836 331 [[#rpT_PrimaireTumorCodelijst]]
rect 670 255 836 291 [[#rcT_PrimaireTumorCodelijst]]
rect 670 246 836 282 [[#rcT_PrimaireTumorCodelijst]]
rect 670 206 836 242 [[#ypT_PrimaireTumorCodelijst]]
rect 670 197 836 233 [[#ypT_PrimaireTumorCodelijst]]
rect 670 151 836 187 [[#pT_PrimaireTumorCodelijst]]
rect 670 148 836 184 [[#pT_PrimaireTumorCodelijst]]
rect 670 103 836 139 [[#ycT_PrimaireTumorCodelijst]]
rect 670 99 836 135 [[#ycT_PrimaireTumorCodelijst]]
rect 670 50 836 86 [[#cT_PrimaireTumorCodelijst]]
rect 670 50 836 86 [[#cT_PrimaireTumorCodelijst]]
rect 143 268 316 318 [[#m_AantalPrimaireTumorenCodelijst]]
rect 141 267 314 317 [[#m_AantalPrimaireTumorenCodelijst]]
rect 327 740 442 810 [[AnatomischeLocatie-v1.0(2020NL)]]
rect 327 740 442 810 [[AnatomischeLocatie-v1.0(2020NL)]]
rect 463 662 667 712 [[#G_DifferentiatiegraadTumorCodelijst]]
rect 463 662 667 712 [[#G_DifferentiatiegraadTumorCodelijst]]
Regel 145: Regel 145:
rect 551 212 722 262 [[#pN_RegionaleLymfeklierenCodelijst]]
rect 551 212 722 262 [[#pN_RegionaleLymfeklierenCodelijst]]
rect 551 149 722 199 [[#ycN_RegionaleLymfeklierenCodelijst]]
rect 551 149 722 199 [[#ycN_RegionaleLymfeklierenCodelijst]]
rect 551 86 722 136 [[#cN_RegionaleLymfeklierenCodelijst]]
rect 550 89 721 139 [[#cN_RegionaleLymfeklierenCodelijst]]
rect 217 367 318 437 [[AnatomischeLocatie-v1.0(2020NL)]]
rect 217 367 318 437 [[AnatomischeLocatie-v1.0(2020NL)]]
rect 180 249 355 319 [[#14179]]
rect 180 249 355 319 [[#14179]]
Regel 202: Regel 202:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277208005 277208005] M category</span>
|<span title = "Codesystem: SNOMED CT; M category (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277208005 277208005] M-categorie van Tumor-Node-Metastasis-classificatie</span>
|}
|}
|
|
Regel 224: Regel 224:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Site of distant metastasis</span>
|<span title = "Codesystem: SNOMED CT; Site of distant metastasis (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Locatie van metastase op afstand</span>
|}
|}
|
|
Regel 239: Regel 239:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Site of distant metastasis</span>
|<span title = "Codesystem: SNOMED CT; Site of distant metastasis (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Locatie van metastase op afstand</span>
|}
|}
|
|
Regel 270: Regel 270:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277206009 277206009] N category</span>
|<span title = "Codesystem: SNOMED CT; N category (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277206009 277206009] N-categorie van tumor-node-metastasis-classificatie</span>
|}
|}
|
|
Regel 315: Regel 315:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=397440000 397440000] Site of involved lymph node</span>
|<span title = "Codesystem: SNOMED CT; Site of involved lymph node (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=397440000 397440000] Locatie van aangedane lymfeklier</span>
|}
|}
|
|
Regel 346: Regel 346:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT&#xA;Onbekende code" style = "color:red">133641000146103 number of primary tumors</span>
|<span title = "Codesystem: SNOMED CT; Number of primary tumors (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=133641000146103 133641000146103] Aantal primaire tumoren</span>
|}
|}
|
|
Regel 364: Regel 364:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=78873005 78873005] T category</span>
|<span title = "Codesystem: SNOMED CT; T category (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=78873005 78873005] T-categorie van Tumor-Node-Metastasis-classificatie</span>
|}
|}
|
|
Regel 460: Regel 460:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Primary tumor site</span>
|<span title = "Codesystem: SNOMED CT; Primary tumor site (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Locatie van primaire tumor</span>
|}
|}
|
|
Regel 476: Regel 476:
{|
{|
|-
|-
|<span title = "Codesystem: SNOMED CT (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Primary tumor site</span>
|<span title = "Codesystem: SNOMED CT; Primary tumor site (observable entity)" >[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Locatie van primaire tumor</span>
|}
|}
|
|
Regel 755: Regel 755:


==Instructions==
==Instructions==
<b>Van een generieke TNM classificatie naar een ziekte specifieke TNM classificatie</b>
<b>Van een generieke TNM classificatie naar een ziekte specifieke TNM classificatie</b><br>
Bij het uitwerken van een tumor specifieke TNM-bouwsteen of implementatie moet gekeken worden hoe de waardelijsten kunnen worden <u>ingeperkt</u>, <u>toegepast</u> of <u>uitgebreid</u>.<BR>
Bij het uitwerken van een tumor specifieke TNM-bouwsteen of implementatie moet gekeken worden hoe de waardelijsten kunnen worden <u>ingeperkt</u>, <u>toegepast</u> of <u>uitgebreid</u>.<BR>
Inperken wil zeggen dat items in een codelijst worden weggelaten of specifiek worden gemaakt door binnen het voorgeschreven code systeem andere termen te kiezen. Het is de bedoeling dat in de toekomst kant en klare codelijsten per kankeraandoening beschikbaar worden gemaakt (zie ook issues).<BR>
Inperken wil zeggen dat items in een codelijst worden weggelaten of specifiek worden gemaakt door binnen het voorgeschreven code systeem andere termen te kiezen. Het is de bedoeling dat in de toekomst kant en klare codelijsten per kankeraandoening beschikbaar worden gemaakt (zie ook issues).<BR>
<b>Codesystemen</b>
<b>Codesystemen</b><br>
In deze zib worden 2 internationale codesystemen gebruikt:<BR>
In deze zib worden 2 internationale codesystemen gebruikt:<BR>
<ul>
<ul>
Regel 764: Regel 764:
<li>International Classification of Diseases for Oncology, version 3 (ICD-O-3) beheerd door de WHO.</li>
<li>International Classification of Diseases for Oncology, version 3 (ICD-O-3) beheerd door de WHO.</li>
</ul>
</ul>
Waar toepassing van één van deze codesystemen niet zinvol werd geacht of mogelijk was is gekozen voor beheer ervan als onderdeel van het beheer van de zibs. Wanneer er een eenduidige internationale verwijzing mogelijk is naar de TNM standaard zelf als codesysteem met waardelijsten kunnen deze worden aangepast in een volgende versie van de zib. <b>Uitgangspunten vanuit de TNM standaard</b>
Waar toepassing van één van deze codesystemen niet zinvol werd geacht of mogelijk was is gekozen voor beheer ervan als onderdeel van het beheer van de zibs. Wanneer er een eenduidige internationale verwijzing mogelijk is naar de TNM standaard zelf als codesysteem met waardelijsten kunnen deze worden aangepast in een volgende versie van de zib.<BR>
<b>Uitgangspunten vanuit de TNM standaard</b>
<ul>
<ul>
<li>Eén TNM-classificatie per orgaan, maar in geval van gepaarde organen is er één classificatie per zijde. Bijvoorbeeld bij borstkanker met in iedere borst een primaire tumor zijn er dan dus ook twee instantiaties van de zib, waarbij de ene lateraliteit links en de andere lateraliteit rechts heeft (beiderzijds is niet toegestaan bij gepaarde organen).</li>
<li>Eén TNM-classificatie per orgaan, maar in geval van gepaarde organen is er één classificatie per zijde. Bijvoorbeeld bij borstkanker met in iedere borst een primaire tumor zijn er dan dus ook twee instantiaties van de zib, waarbij de ene lateraliteit links en de andere lateraliteit rechts heeft (beiderzijds is niet toegestaan bij gepaarde organen).</li>
Regel 770: Regel 771:
<li>In het geval van meerdere primaire tumoren in één orgaan, moet de tumor met de hoogste T-categorie worden geclassificeerd en moet de veelvoud of het aantal tumoren tussen haakjes worden vermeld, bijvoorbeeld T2 (m) of T2 (5).De afwijking met de hoogste T-categorie bepaalt de classificatie van de tumor. Om het onderscheid hierin te maken en alle afwijkingen te kunnen weergeven bestaat de container ‘afwijking’ in de zib. Elke afwijking heeft een nummer. Welke afwijking (b.v. 1, 2 of 4) de hoogste t-categorie heeft wordt niet in de zib aangegeven. Dit is logische want dit is pas duidelijk na de inschatting van de zorgverlener o.b.v. de pathologie dan wel beeldvorming.</li>
<li>In het geval van meerdere primaire tumoren in één orgaan, moet de tumor met de hoogste T-categorie worden geclassificeerd en moet de veelvoud of het aantal tumoren tussen haakjes worden vermeld, bijvoorbeeld T2 (m) of T2 (5).De afwijking met de hoogste T-categorie bepaalt de classificatie van de tumor. Om het onderscheid hierin te maken en alle afwijkingen te kunnen weergeven bestaat de container ‘afwijking’ in de zib. Elke afwijking heeft een nummer. Welke afwijking (b.v. 1, 2 of 4) de hoogste t-categorie heeft wordt niet in de zib aangegeven. Dit is logische want dit is pas duidelijk na de inschatting van de zorgverlener o.b.v. de pathologie dan wel beeldvorming.</li>
</ul>
</ul>
<b>Gebruikte versie van de </b><b><u>UICC (</u></b><a href="$inet://http://www.uicc.org/resources/tnm"><font color="#0000ff"><b><u>http://www.uicc.org/resources/tnm</u></b></font></a><b><u>) </u></b><b>/ </b><b><u>AJCC (</u></b><a href="$inet://http://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx"><font color="#0000ff"><b><u>http://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx</u></b></font></a><b><u> )</u></b><b> TNM Classification of Malignant Tumours.</b>
<b>Gebruikte versie van de [http://www.uicc.org/resources/tnm UICC] / [http://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx AJCC] TNM Classification of Malignant Tumours.</b>
<ul>
<ul>
<li>Hoewel er geen verschillen in definities en verwoordingen tussen AJCC en UICC TNM classificaties zouden mogen voorkomen zijn er helaas wel enkele verschillen ingeslopen (bijvoorbeeld bij de definitie van regionale lymfeklieren bij slokdarm- en endometriumcarcinomen). Daarom kan in deze zib gekozen worden tussen de UICC en AJCC versie. Criteria die in het TNM-classificatiesysteem worden gebruikt, zijn in de loop van de jaren veranderd en er zijn verschillende edities uitgebracht. Als gevolg hiervan kan een bepaalde stagering een heel andere prognose hebben, afhankelijk van welke editie wordt gebruikt. Verder is een belangrijke overweging het effect van een verbeterde behandeling in de tijd</li>
<li>Hoewel er geen verschillen in definities en verwoordingen tussen AJCC en UICC TNM classificaties zouden mogen voorkomen zijn er helaas wel enkele verschillen ingeslopen (bijvoorbeeld bij de definitie van regionale lymfeklieren bij slokdarm- en endometriumcarcinomen). Daarom kan in deze zib gekozen worden tussen de UICC en AJCC versie. Criteria die in het TNM-classificatiesysteem worden gebruikt, zijn in de loop van de jaren veranderd en er zijn verschillende edities uitgebracht. Als gevolg hiervan kan een bepaalde stagering een heel andere prognose hebben, afhankelijk van welke editie wordt gebruikt. Verder is een belangrijke overweging het effect van een verbeterde behandeling in de tijd</li>
Regel 937: Regel 938:
|aNX
|aNX
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aNX
|aNX
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 943: Regel 944:
|aNX(f)
|aNX(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aNX(f)
|aNX(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 949: Regel 950:
|aNX(sn)
|aNX(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aNX(sn)
|aNX(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 955: Regel 956:
|aN0
|aN0
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0
|aN0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 961: Regel 962:
|aN0(f)
|aN0(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(f)
|aN0(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 967: Regel 968:
|aN0(sn)
|aN0(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(sn)
|aN0(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 973: Regel 974:
|aN0(i-)
|aN0(i-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(i-)
|aN0(i-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 979: Regel 980:
|aN0(i-)(sn)
|aN0(i-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(i-)(sn)
|aN0(i-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 985: Regel 986:
|aN0(i+)
|aN0(i+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(i+)
|aN0(i+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 991: Regel 992:
|aN0(i+)(sn)
|aN0(i+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(i+)(sn)
|aN0(i+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 997: Regel 998:
|aN0(mol-)
|aN0(mol-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(mol-)
|aN0(mol-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.003: Regel 1.004:
|aN0(mol-)(sn)
|aN0(mol-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(mol-)(sn)
|aN0(mol-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.009: Regel 1.010:
|aN0(mol+)
|aN0(mol+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(mol+)
|aN0(mol+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.015: Regel 1.016:
|aN0(mol+)(sn)
|aN0(mol+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN0(mol+)(sn)
|aN0(mol+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.021: Regel 1.022:
|aN1
|aN1
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1
|aN1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.027: Regel 1.028:
|aN1(f)
|aN1(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1(f)
|aN1(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.033: Regel 1.034:
|aN1(sn)
|aN1(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1(sn)
|aN1(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.039: Regel 1.040:
|aN1mi
|aN1mi
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1mi
|aN1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.045: Regel 1.046:
|aN1mi(f)
|aN1mi(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1mi(f)
|aN1mi(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.051: Regel 1.052:
|aN1mi(sn)
|aN1mi(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1mi(sn)
|aN1mi(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.057: Regel 1.058:
|aN1a
|aN1a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1a
|aN1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.063: Regel 1.064:
|aN1a(f)
|aN1a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1a(f)
|aN1a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.069: Regel 1.070:
|aN1a(sn)
|aN1a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1a(sn)
|aN1a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.075: Regel 1.076:
|aN1b
|aN1b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1b
|aN1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.081: Regel 1.082:
|aN1b(f)
|aN1b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1b(f)
|aN1b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.087: Regel 1.088:
|aN1b(sn)
|aN1b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1b(sn)
|aN1b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.093: Regel 1.094:
|aN1c
|aN1c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1c
|aN1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.099: Regel 1.100:
|aN1c(f)
|aN1c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1c(f)
|aN1c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.105: Regel 1.106:
|aN1c(sn)
|aN1c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN1c(sn)
|aN1c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.111: Regel 1.112:
|aN2
|aN2
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2
|aN2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.117: Regel 1.118:
|aN2(f)
|aN2(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2(f)
|aN2(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.123: Regel 1.124:
|aN2(sn)
|aN2(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2(sn)
|aN2(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.129: Regel 1.130:
|aN2a
|aN2a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2a
|aN2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.135: Regel 1.136:
|aN2a(f)
|aN2a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2a(f)
|aN2a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.141: Regel 1.142:
|aN2a(sn)
|aN2a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2a(sn)
|aN2a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.147: Regel 1.148:
|aN2b
|aN2b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2b
|aN2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.153: Regel 1.154:
|aN2b(f)
|aN2b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2b(f)
|aN2b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.159: Regel 1.160:
|aN2b(sn)
|aN2b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2b(sn)
|aN2b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.165: Regel 1.166:
|aN2c
|aN2c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2c
|aN2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.171: Regel 1.172:
|aN2c(f)
|aN2c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2c(f)
|aN2c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.177: Regel 1.178:
|aN2c(sn)
|aN2c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN2c(sn)
|aN2c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.183: Regel 1.184:
|aN3
|aN3
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3
|aN3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.189: Regel 1.190:
|aN3(f)
|aN3(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3(f)
|aN3(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.195: Regel 1.196:
|aN3(sn)
|aN3(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3(sn)
|aN3(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.201: Regel 1.202:
|aN3a
|aN3a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3a
|aN3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.207: Regel 1.208:
|aN3a(f)
|aN3a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3a(f)
|aN3a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.213: Regel 1.214:
|aN3a(sn)
|aN3a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3a(sn)
|aN3a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.219: Regel 1.220:
|aN3b
|aN3b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3b
|aN3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.225: Regel 1.226:
|aN3b(f)
|aN3b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3b(f)
|aN3b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.231: Regel 1.232:
|aN3b(sn)
|aN3b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3b(sn)
|aN3b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.237: Regel 1.238:
|aN3c
|aN3c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3c
|aN3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.243: Regel 1.244:
|aN3c(f)
|aN3c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3c(f)
|aN3c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.249: Regel 1.250:
|aN3c(sn)
|aN3c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|aN3c(sn)
|aN3c(sn)
|}
|}
Regel 1.462: Regel 1.463:
|aTx
|aTx
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTx
|aTx
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.468: Regel 1.469:
|aT0
|aT0
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT0
|aT0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.474: Regel 1.475:
|aTa
|aTa
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTa
|aTa
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.480: Regel 1.481:
|aTis
|aTis
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTis
|aTis
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.486: Regel 1.487:
|aTis (DCIS)
|aTis (DCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTis (DCIS)
|aTis (DCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.492: Regel 1.493:
|aTis (LAMN)
|aTis (LAMN)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTis (LAMN)
|aTis (LAMN)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.498: Regel 1.499:
|aTis (LCIS)
|aTis (LCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTis (LCIS)
|aTis (LCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.504: Regel 1.505:
|aTis (Paget)
|aTis (Paget)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTis (Paget)
|aTis (Paget)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.510: Regel 1.511:
|aTis pu
|aTis pu
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aTis pu
|aTis pu
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.516: Regel 1.517:
|aT1
|aT1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1
|aT1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.522: Regel 1.523:
|aT1mi
|aT1mi
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1mi
|aT1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.528: Regel 1.529:
|aT1a
|aT1a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1a
|aT1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.534: Regel 1.535:
|aT1a1
|aT1a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1a1
|aT1a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.540: Regel 1.541:
|aT1a2
|aT1a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1a2
|aT1a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.546: Regel 1.547:
|aT1b
|aT1b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1b
|aT1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.552: Regel 1.553:
|aT1b1
|aT1b1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1b1
|aT1b1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.558: Regel 1.559:
|aT1b2
|aT1b2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1b2
|aT1b2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.564: Regel 1.565:
|aT1c
|aT1c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1c
|aT1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.570: Regel 1.571:
|aT1c1
|aT1c1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1c1
|aT1c1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.576: Regel 1.577:
|aT1c2
|aT1c2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1c2
|aT1c2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.582: Regel 1.583:
|aT1c3
|aT1c3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1c3
|aT1c3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.588: Regel 1.589:
|aT1d
|aT1d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT1d
|aT1d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.594: Regel 1.595:
|aT2
|aT2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT2
|aT2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.600: Regel 1.601:
|aT2a
|aT2a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT2a
|aT2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.606: Regel 1.607:
|aT2a1
|aT2a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT2a1
|aT2a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.612: Regel 1.613:
|aT2a2
|aT2a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT2a2
|aT2a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.618: Regel 1.619:
|aT2b
|aT2b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT2b
|aT2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.624: Regel 1.625:
|aT2c
|aT2c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT2c
|aT2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.630: Regel 1.631:
|aT2d
|aT2d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT2d
|aT2d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.636: Regel 1.637:
|aT3
|aT3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT3
|aT3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.642: Regel 1.643:
|aT3a
|aT3a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT3a
|aT3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.648: Regel 1.649:
|aT3b
|aT3b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT3b
|aT3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.654: Regel 1.655:
|aT3c
|aT3c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT3c
|aT3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.660: Regel 1.661:
|aT3d
|aT3d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT3d
|aT3d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.666: Regel 1.667:
|aT3e
|aT3e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT3e
|aT3e
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.672: Regel 1.673:
|aT4
|aT4
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT4
|aT4
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.678: Regel 1.679:
|aT4a
|aT4a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT4a
|aT4a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.684: Regel 1.685:
|aT4b
|aT4b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT4b
|aT4b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.690: Regel 1.691:
|aT4c
|aT4c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT4c
|aT4c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.696: Regel 1.697:
|aT4d
|aT4d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT4d
|aT4d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.702: Regel 1.703:
|aT4e
|aT4e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|aT4e
|aT4e
|}
|}
Regel 1.722: Regel 1.723:
|cNX
|cNX
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cNX
|cNX
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.728: Regel 1.729:
|cNX(f)
|cNX(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cNX(f)
|cNX(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.734: Regel 1.735:
|cNX(sn)
|cNX(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cNX(sn)
|cNX(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.740: Regel 1.741:
|cN0
|cN0
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0
|cN0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.746: Regel 1.747:
|cN0(f)
|cN0(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(f)
|cN0(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.752: Regel 1.753:
|cN0(sn)
|cN0(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(sn)
|cN0(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.758: Regel 1.759:
|cN0(i-)
|cN0(i-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(i-)
|cN0(i-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.764: Regel 1.765:
|cN0(i-)(sn)
|cN0(i-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(i-)(sn)
|cN0(i-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.770: Regel 1.771:
|cN0(i+)
|cN0(i+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(i+)
|cN0(i+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.776: Regel 1.777:
|cN0(i+)(sn)
|cN0(i+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(i+)(sn)
|cN0(i+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.782: Regel 1.783:
|cN0(mol-)
|cN0(mol-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(mol-)
|cN0(mol-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.788: Regel 1.789:
|cN0(mol-)(sn)
|cN0(mol-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(mol-)(sn)
|cN0(mol-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.794: Regel 1.795:
|cN0(mol+)
|cN0(mol+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(mol+)
|cN0(mol+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.800: Regel 1.801:
|cN0(mol+)(sn)
|cN0(mol+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN0(mol+)(sn)
|cN0(mol+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.806: Regel 1.807:
|cN1
|cN1
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1
|cN1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.812: Regel 1.813:
|cN1(f)
|cN1(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1(f)
|cN1(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.818: Regel 1.819:
|cN1(sn)
|cN1(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1(sn)
|cN1(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.824: Regel 1.825:
|cN1mi
|cN1mi
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1mi
|cN1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.830: Regel 1.831:
|cN1mi(f)
|cN1mi(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1mi(f)
|cN1mi(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.836: Regel 1.837:
|cN1mi(sn)
|cN1mi(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1mi(sn)
|cN1mi(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.842: Regel 1.843:
|cN1a
|cN1a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1a
|cN1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.848: Regel 1.849:
|cN1a(f)
|cN1a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1a(f)
|cN1a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.854: Regel 1.855:
|cN1a(sn)
|cN1a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1a(sn)
|cN1a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.860: Regel 1.861:
|cN1b
|cN1b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1b
|cN1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.866: Regel 1.867:
|cN1b(f)
|cN1b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1b(f)
|cN1b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.872: Regel 1.873:
|cN1b(sn)
|cN1b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1b(sn)
|cN1b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.878: Regel 1.879:
|cN1c
|cN1c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1c
|cN1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.884: Regel 1.885:
|cN1c(f)
|cN1c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1c(f)
|cN1c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.890: Regel 1.891:
|cN1c(sn)
|cN1c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN1c(sn)
|cN1c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.896: Regel 1.897:
|cN2
|cN2
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2
|cN2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.902: Regel 1.903:
|cN2(f)
|cN2(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2(f)
|cN2(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.908: Regel 1.909:
|cN2(sn)
|cN2(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2(sn)
|cN2(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.914: Regel 1.915:
|cN2a
|cN2a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2a
|cN2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.920: Regel 1.921:
|cN2a(f)
|cN2a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2a(f)
|cN2a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.926: Regel 1.927:
|cN2a(sn)
|cN2a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2a(sn)
|cN2a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.932: Regel 1.933:
|cN2b
|cN2b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2b
|cN2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.938: Regel 1.939:
|cN2b(f)
|cN2b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2b(f)
|cN2b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.944: Regel 1.945:
|cN2b(sn)
|cN2b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2b(sn)
|cN2b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.950: Regel 1.951:
|cN2c
|cN2c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2c
|cN2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.956: Regel 1.957:
|cN2c(f)
|cN2c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2c(f)
|cN2c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.962: Regel 1.963:
|cN2c(sn)
|cN2c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN2c(sn)
|cN2c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.968: Regel 1.969:
|cN3
|cN3
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3
|cN3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.974: Regel 1.975:
|cN3(f)
|cN3(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3(f)
|cN3(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.980: Regel 1.981:
|cN3(sn)
|cN3(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3(sn)
|cN3(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.986: Regel 1.987:
|cN3a
|cN3a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3a
|cN3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.992: Regel 1.993:
|cN3a(f)
|cN3a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3a(f)
|cN3a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 1.998: Regel 1.999:
|cN3a(sn)
|cN3a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3a(sn)
|cN3a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.004: Regel 2.005:
|cN3b
|cN3b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3b
|cN3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.010: Regel 2.011:
|cN3b(f)
|cN3b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3b(f)
|cN3b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.016: Regel 2.017:
|cN3b(sn)
|cN3b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3b(sn)
|cN3b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.022: Regel 2.023:
|cN3c
|cN3c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3c
|cN3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.028: Regel 2.029:
|cN3c(f)
|cN3c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3c(f)
|cN3c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.034: Regel 2.035:
|cN3c(sn)
|cN3c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|cN3c(sn)
|cN3c(sn)
|}
|}
Regel 2.242: Regel 2.243:
|cTx
|cTx
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTx
|cTx
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.248: Regel 2.249:
|cT0
|cT0
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT0
|cT0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.254: Regel 2.255:
|cTa
|cTa
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTa
|cTa
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.260: Regel 2.261:
|cTis
|cTis
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTis
|cTis
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.266: Regel 2.267:
|cTis (DCIS)
|cTis (DCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTis (DCIS)
|cTis (DCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.272: Regel 2.273:
|cTis (LAMN)
|cTis (LAMN)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTis (LAMN)
|cTis (LAMN)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.278: Regel 2.279:
|cTis (LCIS)
|cTis (LCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTis (LCIS)
|cTis (LCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.284: Regel 2.285:
|cTis (Paget)
|cTis (Paget)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTis (Paget)
|cTis (Paget)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.290: Regel 2.291:
|cTis pu
|cTis pu
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cTis pu
|cTis pu
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.296: Regel 2.297:
|cT1
|cT1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1
|cT1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.302: Regel 2.303:
|cT1mi
|cT1mi
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1mi
|cT1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.308: Regel 2.309:
|cT1a
|cT1a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1a
|cT1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.314: Regel 2.315:
|cT1a1
|cT1a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1a1
|cT1a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.320: Regel 2.321:
|cT1a2
|cT1a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1a2
|cT1a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.326: Regel 2.327:
|cT1b
|cT1b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1b
|cT1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.332: Regel 2.333:
|cT1b1
|cT1b1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1b1
|cT1b1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.338: Regel 2.339:
|cT1b2
|cT1b2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1b2
|cT1b2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.344: Regel 2.345:
|cT1c
|cT1c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1c
|cT1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.350: Regel 2.351:
|cT1c1
|cT1c1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1c1
|cT1c1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.356: Regel 2.357:
|cT1c2
|cT1c2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1c2
|cT1c2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.362: Regel 2.363:
|cT1c3
|cT1c3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1c3
|cT1c3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.368: Regel 2.369:
|cT1d
|cT1d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT1d
|cT1d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.374: Regel 2.375:
|cT2
|cT2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT2
|cT2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.380: Regel 2.381:
|cT2a
|cT2a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT2a
|cT2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.386: Regel 2.387:
|cT2a1
|cT2a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT2a1
|cT2a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.392: Regel 2.393:
|cT2a2
|cT2a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT2a2
|cT2a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.398: Regel 2.399:
|cT2b
|cT2b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT2b
|cT2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.404: Regel 2.405:
|cT2c
|cT2c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT2c
|cT2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.410: Regel 2.411:
|cT2d
|cT2d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT2d
|cT2d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.416: Regel 2.417:
|cT3
|cT3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT3
|cT3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.422: Regel 2.423:
|cT3a
|cT3a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT3a
|cT3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.428: Regel 2.429:
|cT3b
|cT3b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT3b
|cT3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.434: Regel 2.435:
|cT3c
|cT3c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT3c
|cT3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.440: Regel 2.441:
|cT3d
|cT3d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT3d
|cT3d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.446: Regel 2.447:
|cT3e
|cT3e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT3e
|cT3e
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.452: Regel 2.453:
|cT4
|cT4
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT4
|cT4
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.458: Regel 2.459:
|cT4a
|cT4a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT4a
|cT4a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.464: Regel 2.465:
|cT4b
|cT4b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT4b
|cT4b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.470: Regel 2.471:
|cT4c
|cT4c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT4c
|cT4c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.476: Regel 2.477:
|cT4d
|cT4d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT4d
|cT4d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.482: Regel 2.483:
|cT4e
|cT4e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|cT4e
|cT4e
|}
|}
Regel 2.503: Regel 2.504:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|Differentiatiegraad kan niet beoordeeld worden.Grade cannot be assessed.
|Differentiatiegraad kan niet beoordeeld worden.
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|G1
|G1
Regel 2.509: Regel 2.510:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|Goed gedifferentieerd.Well differentiated.
|Goed gedifferentieerd.
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|G2
|G2
Regel 2.515: Regel 2.516:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|Matig gedifferentieerd.Moderately differentiated.
|Matig gedifferentieerd.
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|G3
|G3
Regel 2.521: Regel 2.522:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|Slecht gedifferentieerd.Poorly differentiated.
|Slecht gedifferentieerd.
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|G3-4
|G3-4
Regel 2.527: Regel 2.528:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|Slecht gedifferentieerd of ongedifferentieerd.poorly differentiated or undifferentiated.
|Slecht gedifferentieerd of ongedifferentieerd.
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|G4
|G4
Regel 2.533: Regel 2.534:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|Ongedifferentieerd.Undifferentiated.
|Ongedifferentieerd.
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|G5
|G5
Regel 2.539: Regel 2.540:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|G5
|Differentiatiegraad groep 5 (Gleason score: 9-10)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|LowMitoticRate
|LowMitoticRate
Regel 2.545: Regel 2.546:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|LowMitoticRate
|Lage mitotische rato
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|HighMitoticRate
|HighMitoticRate
Regel 2.551: Regel 2.552:
|G_DifferentiatiegraadTumor
|G_DifferentiatiegraadTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5
|HighMitoticRate
|Hoge mitotische rato
|}
|}
=== L_LymfatischeInvasieCodelijst===
=== L_LymfatischeInvasieCodelijst===
Regel 2.665: Regel 2.666:
|Other
|Other
|OTH
|OTH
|nullflavor
|NullFlavor
|2.16.840.1.113883.5.1008
|2.16.840.1.113883.5.1008
|Anders, specificeer.
|Anders, specificeer.
Regel 2.700: Regel 2.701:
|PnX
|PnX
|Pn_PerineuraleInvasie
|Pn_PerineuraleInvasie
|2.16.840.1.113883.2.4.3.11.60.40.5.1.
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3
|Aanwezigheid van Perineurale invasie kan niet beoordeeld worden
|Aanwezigheid van Perineurale invasie kan niet beoordeeld worden
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.731: Regel 2.732:
|pNX
|pNX
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pNX
|pNX
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.737: Regel 2.738:
|pNX(f)
|pNX(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pNX(f)
|pNX(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.743: Regel 2.744:
|pNX(sn)
|pNX(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pNX(sn)
|pNX(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.749: Regel 2.750:
|pN0
|pN0
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0
|pN0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.755: Regel 2.756:
|pN0(f)
|pN0(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(f)
|pN0(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.761: Regel 2.762:
|pN0(sn)
|pN0(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(sn)
|pN0(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.767: Regel 2.768:
|pN0(i-)
|pN0(i-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(i-)
|pN0(i-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.773: Regel 2.774:
|pN0(i-)(sn)
|pN0(i-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(i-)(sn)
|pN0(i-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.779: Regel 2.780:
|pN0(i+)
|pN0(i+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(i+)
|pN0(i+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.785: Regel 2.786:
|pN0(i+)(sn)
|pN0(i+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(i+)(sn)
|pN0(i+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.791: Regel 2.792:
|pN0(mol-)
|pN0(mol-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(mol-)
|pN0(mol-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.797: Regel 2.798:
|pN0(mol-)(sn)
|pN0(mol-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(mol-)(sn)
|pN0(mol-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.803: Regel 2.804:
|pN0(mol+)
|pN0(mol+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(mol+)
|pN0(mol+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.809: Regel 2.810:
|pN0(mol+)(sn)
|pN0(mol+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN0(mol+)(sn)
|pN0(mol+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.815: Regel 2.816:
|pN1
|pN1
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1
|pN1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.821: Regel 2.822:
|pN1(f)
|pN1(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1(f)
|pN1(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.827: Regel 2.828:
|pN1(sn)
|pN1(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1(sn)
|pN1(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.833: Regel 2.834:
|pN1mi
|pN1mi
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1mi
|pN1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.839: Regel 2.840:
|pN1mi(f)
|pN1mi(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1mi(f)
|pN1mi(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.845: Regel 2.846:
|pN1mi(sn)
|pN1mi(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1mi(sn)
|pN1mi(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.851: Regel 2.852:
|pN1a
|pN1a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1a
|pN1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.857: Regel 2.858:
|pN1a(f)
|pN1a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1a(f)
|pN1a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.863: Regel 2.864:
|pN1a(sn)
|pN1a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1a(sn)
|pN1a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.869: Regel 2.870:
|pN1b
|pN1b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1b
|pN1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.875: Regel 2.876:
|pN1b(f)
|pN1b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1b(f)
|pN1b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.881: Regel 2.882:
|pN1b(sn)
|pN1b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1b(sn)
|pN1b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.887: Regel 2.888:
|pN1c
|pN1c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1c
|pN1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.893: Regel 2.894:
|pN1c(f)
|pN1c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1c(f)
|pN1c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.899: Regel 2.900:
|pN1c(sn)
|pN1c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN1c(sn)
|pN1c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.905: Regel 2.906:
|pN2
|pN2
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2
|pN2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.911: Regel 2.912:
|pN2(f)
|pN2(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2(f)
|pN2(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.917: Regel 2.918:
|pN2(sn)
|pN2(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2(sn)
|pN2(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.923: Regel 2.924:
|pN2a
|pN2a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2a
|pN2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.929: Regel 2.930:
|pN2a(f)
|pN2a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2a(f)
|pN2a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.935: Regel 2.936:
|pN2a(sn)
|pN2a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2a(sn)
|pN2a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.941: Regel 2.942:
|pN2b
|pN2b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2b
|pN2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.947: Regel 2.948:
|pN2b(f)
|pN2b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2b(f)
|pN2b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.953: Regel 2.954:
|pN2b(sn)
|pN2b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2b(sn)
|pN2b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.959: Regel 2.960:
|pN2c
|pN2c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2c
|pN2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.965: Regel 2.966:
|pN2c(f)
|pN2c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2c(f)
|pN2c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.971: Regel 2.972:
|pN2c(sn)
|pN2c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN2c(sn)
|pN2c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.977: Regel 2.978:
|pN3
|pN3
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3
|pN3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.983: Regel 2.984:
|pN3(f)
|pN3(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3(f)
|pN3(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.989: Regel 2.990:
|pN3(sn)
|pN3(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3(sn)
|pN3(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 2.995: Regel 2.996:
|pN3a
|pN3a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3a
|pN3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.001: Regel 3.002:
|pN3a(f)
|pN3a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3a(f)
|pN3a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.007: Regel 3.008:
|pN3a(sn)
|pN3a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3a(sn)
|pN3a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.013: Regel 3.014:
|pN3b
|pN3b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3b
|pN3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.019: Regel 3.020:
|pN3b(f)
|pN3b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3b(f)
|pN3b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.025: Regel 3.026:
|pN3b(sn)
|pN3b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3b(sn)
|pN3b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.031: Regel 3.032:
|pN3c
|pN3c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3c
|pN3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.037: Regel 3.038:
|pN3c(f)
|pN3c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3c(f)
|pN3c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.043: Regel 3.044:
|pN3c(sn)
|pN3c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|pN3c(sn)
|pN3c(sn)
|}
|}
Regel 3.256: Regel 3.257:
|pTx
|pTx
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTx
|pTx
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.262: Regel 3.263:
|pT0
|pT0
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT0
|pT0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.268: Regel 3.269:
|pTa
|pTa
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTa
|pTa
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.274: Regel 3.275:
|pTis
|pTis
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTis
|pTis
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.280: Regel 3.281:
|pTis (DCIS)
|pTis (DCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTis (DCIS)
|pTis (DCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.286: Regel 3.287:
|pTis (LAMN)
|pTis (LAMN)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTis (LAMN)
|pTis (LAMN)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.292: Regel 3.293:
|pTis (LCIS)
|pTis (LCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTis (LCIS)
|pTis (LCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.298: Regel 3.299:
|pTis (Paget)
|pTis (Paget)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTis (Paget)
|pTis (Paget)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.304: Regel 3.305:
|pTis pu
|pTis pu
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pTis pu
|pTis pu
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.310: Regel 3.311:
|pT1
|pT1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1
|pT1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.316: Regel 3.317:
|pT1mi
|pT1mi
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1mi
|pT1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.322: Regel 3.323:
|pT1a
|pT1a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1a
|pT1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.328: Regel 3.329:
|pT1a1
|pT1a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1a1
|pT1a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.334: Regel 3.335:
|pT1a2
|pT1a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1a2
|pT1a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.340: Regel 3.341:
|pT1b
|pT1b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1b
|pT1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.346: Regel 3.347:
|pT1b1
|pT1b1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1b1
|pT1b1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.352: Regel 3.353:
|pT1b2
|pT1b2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1b2
|pT1b2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.358: Regel 3.359:
|pT1c
|pT1c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1c
|pT1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.364: Regel 3.365:
|pT1c1
|pT1c1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1c1
|pT1c1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.370: Regel 3.371:
|pT1c2
|pT1c2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1c2
|pT1c2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.376: Regel 3.377:
|pT1c3
|pT1c3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1c3
|pT1c3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.382: Regel 3.383:
|pT1d
|pT1d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT1d
|pT1d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.388: Regel 3.389:
|pT2
|pT2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT2
|pT2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.394: Regel 3.395:
|pT2a
|pT2a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT2a
|pT2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.400: Regel 3.401:
|pT2a1
|pT2a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT2a1
|pT2a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.406: Regel 3.407:
|pT2a2
|pT2a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT2a2
|pT2a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.412: Regel 3.413:
|pT2b
|pT2b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT2b
|pT2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.418: Regel 3.419:
|pT2c
|pT2c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT2c
|pT2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.424: Regel 3.425:
|pT2d
|pT2d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT2d
|pT2d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.430: Regel 3.431:
|pT3
|pT3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT3
|pT3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.436: Regel 3.437:
|pT3a
|pT3a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT3a
|pT3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.442: Regel 3.443:
|pT3b
|pT3b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT3b
|pT3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.448: Regel 3.449:
|pT3c
|pT3c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT3c
|pT3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.454: Regel 3.455:
|pT3d
|pT3d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT3d
|pT3d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.460: Regel 3.461:
|pT4
|pT4
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT4
|pT4
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.466: Regel 3.467:
|pT4a
|pT4a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT4a
|pT4a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.472: Regel 3.473:
|pT4b
|pT4b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT4b
|pT4b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.478: Regel 3.479:
|pT4c
|pT4c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT4c
|pT4c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.484: Regel 3.485:
|pT4d
|pT4d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT4d
|pT4d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.490: Regel 3.491:
|pT4e
|pT4e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|pT4e
|pT4e
|}
|}
Regel 3.547: Regel 3.548:
|rcNX
|rcNX
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcNX
|rcNX
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.553: Regel 3.554:
|rcNX(f)
|rcNX(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcNX(f)
|rcNX(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.559: Regel 3.560:
|rcNX(sn)
|rcNX(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcNX(sn)
|rcNX(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.565: Regel 3.566:
|rcN0
|rcN0
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0
|rcN0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.571: Regel 3.572:
|rcN0(f)
|rcN0(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(f)
|rcN0(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.577: Regel 3.578:
|rcN0(sn)
|rcN0(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(sn)
|rcN0(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.583: Regel 3.584:
|rcN0(i-)
|rcN0(i-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(i-)
|rcN0(i-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.589: Regel 3.590:
|rcN0(i-)(sn)
|rcN0(i-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(i-)(sn)
|rcN0(i-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.595: Regel 3.596:
|rcN0(i+)
|rcN0(i+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(i+)
|rcN0(i+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.601: Regel 3.602:
|rcN0(i+)(sn)
|rcN0(i+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(i+)(sn)
|rcN0(i+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.607: Regel 3.608:
|rcN0(mol-)
|rcN0(mol-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(mol-)
|rcN0(mol-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.613: Regel 3.614:
|rcN0(mol-)(sn)
|rcN0(mol-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(mol-)(sn)
|rcN0(mol-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.619: Regel 3.620:
|rcN0(mol+)
|rcN0(mol+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(mol+)
|rcN0(mol+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.625: Regel 3.626:
|rcN0(mol+)(sn)
|rcN0(mol+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN0(mol+)(sn)
|rcN0(mol+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.631: Regel 3.632:
|rcN1
|rcN1
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1
|rcN1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.637: Regel 3.638:
|rcN1(f)
|rcN1(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1(f)
|rcN1(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.643: Regel 3.644:
|rcN1(sn)
|rcN1(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1(sn)
|rcN1(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.649: Regel 3.650:
|rcN1mi
|rcN1mi
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1mi
|rcN1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.655: Regel 3.656:
|rcN1mi(f)
|rcN1mi(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1mi(f)
|rcN1mi(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.661: Regel 3.662:
|rcN1mi(sn)
|rcN1mi(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1mi(sn)
|rcN1mi(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.667: Regel 3.668:
|rcN1a
|rcN1a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1a
|rcN1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.673: Regel 3.674:
|rcN1a(f)
|rcN1a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1a(f)
|rcN1a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.679: Regel 3.680:
|rcN1a(sn)
|rcN1a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1a(sn)
|rcN1a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.685: Regel 3.686:
|rcN1b
|rcN1b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1b
|rcN1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.691: Regel 3.692:
|rcN1b(f)
|rcN1b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1b(f)
|rcN1b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.697: Regel 3.698:
|rcN1b(sn)
|rcN1b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1b(sn)
|rcN1b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.703: Regel 3.704:
|rcN1c
|rcN1c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1c
|rcN1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.709: Regel 3.710:
|rcN1c(f)
|rcN1c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1c(f)
|rcN1c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.715: Regel 3.716:
|rcN1c(sn)
|rcN1c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN1c(sn)
|rcN1c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.721: Regel 3.722:
|rcN2
|rcN2
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2
|rcN2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.727: Regel 3.728:
|rcN2(f)
|rcN2(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2(f)
|rcN2(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.733: Regel 3.734:
|rcN2(sn)
|rcN2(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2(sn)
|rcN2(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.739: Regel 3.740:
|rcN2a
|rcN2a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2a
|rcN2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.745: Regel 3.746:
|rcN2a(f)
|rcN2a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2a(f)
|rcN2a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.751: Regel 3.752:
|rcN2a(sn)
|rcN2a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2a(sn)
|rcN2a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.757: Regel 3.758:
|rcN2b
|rcN2b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2b
|rcN2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.763: Regel 3.764:
|rcN2b(f)
|rcN2b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2b(f)
|rcN2b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.769: Regel 3.770:
|rcN2b(sn)
|rcN2b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2b(sn)
|rcN2b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.775: Regel 3.776:
|rcN2c
|rcN2c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2c
|rcN2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.781: Regel 3.782:
|rcN2c(f)
|rcN2c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2c(f)
|rcN2c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.787: Regel 3.788:
|rcN2c(sn)
|rcN2c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN2c(sn)
|rcN2c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.793: Regel 3.794:
|rcN3
|rcN3
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3
|rcN3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.799: Regel 3.800:
|rcN3(f)
|rcN3(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3(f)
|rcN3(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.805: Regel 3.806:
|rcN3(sn)
|rcN3(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3(sn)
|rcN3(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.811: Regel 3.812:
|rcN3a
|rcN3a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3a
|rcN3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.817: Regel 3.818:
|rcN3a(f)
|rcN3a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3a(f)
|rcN3a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.823: Regel 3.824:
|rcN3a(sn)
|rcN3a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3a(sn)
|rcN3a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.829: Regel 3.830:
|rcN3b
|rcN3b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3b
|rcN3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.835: Regel 3.836:
|rcN3b(f)
|rcN3b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3b(f)
|rcN3b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.841: Regel 3.842:
|rcN3b(sn)
|rcN3b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3b(sn)
|rcN3b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.847: Regel 3.848:
|rcN3c
|rcN3c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3c
|rcN3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.853: Regel 3.854:
|rcN3c(f)
|rcN3c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3c(f)
|rcN3c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 3.859: Regel 3.860:
|rcN3c(sn)
|rcN3c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rcN3c(sn)
|rcN3c(sn)
|}
|}
Regel 4.067: Regel 4.068:
|rcTx
|rcTx
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTx
|rcTx
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.073: Regel 4.074:
|rcT0
|rcT0
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT0
|rcT0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.079: Regel 4.080:
|rcTa
|rcTa
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTa
|rcTa
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.085: Regel 4.086:
|rcTis
|rcTis
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTis
|rcTis
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.091: Regel 4.092:
|rcTis (DCIS)
|rcTis (DCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTis (DCIS)
|rcTis (DCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.097: Regel 4.098:
|rcTis (LAMN)
|rcTis (LAMN)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTis (LAMN)
|rcTis (LAMN)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.103: Regel 4.104:
|rcTis (LCIS)
|rcTis (LCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTis (LCIS)
|rcTis (LCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.109: Regel 4.110:
|rcTis (Paget)
|rcTis (Paget)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTis (Paget)
|rcTis (Paget)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.115: Regel 4.116:
|rcTis pu
|rcTis pu
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcTis pu
|rcTis pu
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.121: Regel 4.122:
|rcT1
|rcT1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1
|rcT1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.127: Regel 4.128:
|rcT1mi
|rcT1mi
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1mi
|rcT1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.133: Regel 4.134:
|rcT1a
|rcT1a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1a
|rcT1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.139: Regel 4.140:
|rcT1a1
|rcT1a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1a1
|rcT1a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.145: Regel 4.146:
|rcT1a2
|rcT1a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1a2
|rcT1a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.151: Regel 4.152:
|rcT1b
|rcT1b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1b
|rcT1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.157: Regel 4.158:
|rcT1b1
|rcT1b1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1b1
|rcT1b1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.163: Regel 4.164:
|rcT1b2
|rcT1b2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1b2
|rcT1b2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.169: Regel 4.170:
|rcT1c
|rcT1c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1c
|rcT1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.175: Regel 4.176:
|rcT1c1
|rcT1c1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1c1
|rcT1c1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.181: Regel 4.182:
|rcT1c2
|rcT1c2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1c2
|rcT1c2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.187: Regel 4.188:
|rcT1c3
|rcT1c3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1c3
|rcT1c3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.193: Regel 4.194:
|rcT1d
|rcT1d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT1d
|rcT1d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.199: Regel 4.200:
|rcT2
|rcT2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT2
|rcT2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.205: Regel 4.206:
|rcT2a
|rcT2a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT2a
|rcT2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.211: Regel 4.212:
|rcT2a1
|rcT2a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT2a1
|rcT2a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.217: Regel 4.218:
|rcT2a2
|rcT2a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT2a2
|rcT2a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.223: Regel 4.224:
|rcT2b
|rcT2b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT2b
|rcT2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.229: Regel 4.230:
|rcT2c
|rcT2c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT2c
|rcT2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.235: Regel 4.236:
|rcT2d
|rcT2d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT2d
|rcT2d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.241: Regel 4.242:
|rcT3
|rcT3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT3
|rcT3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.247: Regel 4.248:
|rcT3a
|rcT3a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT3a
|rcT3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.253: Regel 4.254:
|rcT3b
|rcT3b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT3b
|rcT3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.259: Regel 4.260:
|rcT3c
|rcT3c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT3c
|rcT3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.265: Regel 4.266:
|rcT3d
|rcT3d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT3d
|rcT3d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.271: Regel 4.272:
|rcT3e
|rcT3e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT3e
|rcT3e
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.277: Regel 4.278:
|rcT4
|rcT4
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT4
|rcT4
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.283: Regel 4.284:
|rcT4a
|rcT4a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT4a
|rcT4a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.289: Regel 4.290:
|rcT4b
|rcT4b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT4b
|rcT4b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.295: Regel 4.296:
|rcT4c
|rcT4c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT4c
|rcT4c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.301: Regel 4.302:
|rcT4d
|rcT4d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT4d
|rcT4d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.307: Regel 4.308:
|rcT4e
|rcT4e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rcT4e
|rcT4e
|}
|}
Regel 4.327: Regel 4.328:
|rpNX
|rpNX
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpNX
|rpNX
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.333: Regel 4.334:
|rpNX(f)
|rpNX(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpNX(f)
|rpNX(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.339: Regel 4.340:
|rpNX(sn)
|rpNX(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpNX(sn)
|rpNX(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.345: Regel 4.346:
|rpN0
|rpN0
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0
|rpN0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.351: Regel 4.352:
|rpN0(f)
|rpN0(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(f)
|rpN0(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.357: Regel 4.358:
|rpN0(sn)
|rpN0(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(sn)
|rpN0(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.363: Regel 4.364:
|rpN0(i-)
|rpN0(i-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(i-)
|rpN0(i-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.369: Regel 4.370:
|rpN0(i-)(sn)
|rpN0(i-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(i-)(sn)
|rpN0(i-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.375: Regel 4.376:
|rpN0(i+)
|rpN0(i+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(i+)
|rpN0(i+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.381: Regel 4.382:
|rpN0(i+)(sn)
|rpN0(i+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(i+)(sn)
|rpN0(i+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.387: Regel 4.388:
|rpN0(mol-)
|rpN0(mol-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(mol-)
|rpN0(mol-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.393: Regel 4.394:
|rpN0(mol-)(sn)
|rpN0(mol-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(mol-)(sn)
|rpN0(mol-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.399: Regel 4.400:
|rpN0(mol+)
|rpN0(mol+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(mol+)
|rpN0(mol+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.405: Regel 4.406:
|rpN0(mol+)(sn)
|rpN0(mol+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN0(mol+)(sn)
|rpN0(mol+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.411: Regel 4.412:
|rpN1
|rpN1
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1
|rpN1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.417: Regel 4.418:
|rpN1(f)
|rpN1(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1(f)
|rpN1(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.423: Regel 4.424:
|rpN1(sn)
|rpN1(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1(sn)
|rpN1(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.429: Regel 4.430:
|rpN1mi
|rpN1mi
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1mi
|rpN1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.435: Regel 4.436:
|rpN1mi(f)
|rpN1mi(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1mi(f)
|rpN1mi(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.441: Regel 4.442:
|rpN1mi(sn)
|rpN1mi(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1mi(sn)
|rpN1mi(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.447: Regel 4.448:
|rpN1a
|rpN1a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1a
|rpN1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.453: Regel 4.454:
|rpN1a(f)
|rpN1a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1a(f)
|rpN1a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.459: Regel 4.460:
|rpN1a(sn)
|rpN1a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1a(sn)
|rpN1a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.465: Regel 4.466:
|rpN1b
|rpN1b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1b
|rpN1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.471: Regel 4.472:
|rpN1b(f)
|rpN1b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1b(f)
|rpN1b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.477: Regel 4.478:
|rpN1b(sn)
|rpN1b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1b(sn)
|rpN1b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.483: Regel 4.484:
|rpN1c
|rpN1c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1c
|rpN1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.489: Regel 4.490:
|rpN1c(f)
|rpN1c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1c(f)
|rpN1c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.495: Regel 4.496:
|rpN1c(sn)
|rpN1c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN1c(sn)
|rpN1c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.501: Regel 4.502:
|rpN2
|rpN2
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2
|rpN2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.507: Regel 4.508:
|rpN2(f)
|rpN2(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2(f)
|rpN2(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.513: Regel 4.514:
|rpN2(sn)
|rpN2(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2(sn)
|rpN2(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.519: Regel 4.520:
|rpN2a
|rpN2a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2a
|rpN2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.525: Regel 4.526:
|rpN2a(f)
|rpN2a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2a(f)
|rpN2a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.531: Regel 4.532:
|rpN2a(sn)
|rpN2a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2a(sn)
|rpN2a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.537: Regel 4.538:
|rpN2b
|rpN2b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2b
|rpN2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.543: Regel 4.544:
|rpN2b(f)
|rpN2b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2b(f)
|rpN2b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.549: Regel 4.550:
|rpN2b(sn)
|rpN2b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2b(sn)
|rpN2b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.555: Regel 4.556:
|rpN2c
|rpN2c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2c
|rpN2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.561: Regel 4.562:
|rpN2c(f)
|rpN2c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2c(f)
|rpN2c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.567: Regel 4.568:
|rpN2c(sn)
|rpN2c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN2c(sn)
|rpN2c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.573: Regel 4.574:
|rpN3
|rpN3
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3
|rpN3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.579: Regel 4.580:
|rpN3(f)
|rpN3(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3(f)
|rpN3(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.585: Regel 4.586:
|rpN3(sn)
|rpN3(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3(sn)
|rpN3(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.591: Regel 4.592:
|rpN3a
|rpN3a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3a
|rpN3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.597: Regel 4.598:
|rpN3a(f)
|rpN3a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3a(f)
|rpN3a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.603: Regel 4.604:
|rpN3a(sn)
|rpN3a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3a(sn)
|rpN3a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.609: Regel 4.610:
|rpN3b
|rpN3b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3b
|rpN3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.615: Regel 4.616:
|rpN3b(f)
|rpN3b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3b(f)
|rpN3b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.621: Regel 4.622:
|rpN3b(sn)
|rpN3b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3b(sn)
|rpN3b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.627: Regel 4.628:
|rpN3c
|rpN3c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3c
|rpN3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.633: Regel 4.634:
|rpN3c(f)
|rpN3c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3c(f)
|rpN3c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.639: Regel 4.640:
|rpN3c(sn)
|rpN3c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|rpN3c(sn)
|rpN3c(sn)
|}
|}
Regel 4.659: Regel 4.660:
|rpTx
|rpTx
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTx
|rpTx
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.665: Regel 4.666:
|rpT0
|rpT0
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT0
|rpT0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.671: Regel 4.672:
|rpTa
|rpTa
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTa
|rpTa
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.677: Regel 4.678:
|rpTis
|rpTis
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTis
|rpTis
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.683: Regel 4.684:
|rpTis (DCIS)
|rpTis (DCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTis (DCIS)
|rpTis (DCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.689: Regel 4.690:
|rpTis (LAMN)
|rpTis (LAMN)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTis (LAMN)
|rpTis (LAMN)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.695: Regel 4.696:
|rpTis (LCIS)
|rpTis (LCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTis (LCIS)
|rpTis (LCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.701: Regel 4.702:
|rpTis (Paget)
|rpTis (Paget)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTis (Paget)
|rpTis (Paget)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.707: Regel 4.708:
|rpTis pu
|rpTis pu
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpTis pu
|rpTis pu
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.713: Regel 4.714:
|rpT1
|rpT1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1
|rpT1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.719: Regel 4.720:
|rpT1mi
|rpT1mi
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1mi
|rpT1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.725: Regel 4.726:
|rpT1a
|rpT1a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1a
|rpT1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.731: Regel 4.732:
|rpT1a1
|rpT1a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1a1
|rpT1a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.737: Regel 4.738:
|rpT1a2
|rpT1a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1a2
|rpT1a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.743: Regel 4.744:
|rpT1b
|rpT1b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1b
|rpT1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.749: Regel 4.750:
|rpT1b1
|rpT1b1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1b1
|rpT1b1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.755: Regel 4.756:
|rpT1b2
|rpT1b2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1b2
|rpT1b2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.761: Regel 4.762:
|rpT1c
|rpT1c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1c
|rpT1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.767: Regel 4.768:
|rpT1c1
|rpT1c1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1c1
|rpT1c1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.773: Regel 4.774:
|rpT1c2
|rpT1c2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1c2
|rpT1c2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.779: Regel 4.780:
|rpT1c3
|rpT1c3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1c3
|rpT1c3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.785: Regel 4.786:
|rpT1d
|rpT1d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT1d
|rpT1d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.791: Regel 4.792:
|rpT2
|rpT2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT2
|rpT2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.797: Regel 4.798:
|rpT2a
|rpT2a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT2a
|rpT2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.803: Regel 4.804:
|rpT2a1
|rpT2a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT2a1
|rpT2a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.809: Regel 4.810:
|rpT2a2
|rpT2a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT2a2
|rpT2a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.815: Regel 4.816:
|rpT2b
|rpT2b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT2b
|rpT2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.821: Regel 4.822:
|rpT2c
|rpT2c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT2c
|rpT2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.827: Regel 4.828:
|rpT2d
|rpT2d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT2d
|rpT2d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.833: Regel 4.834:
|rpT3
|rpT3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT3
|rpT3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.839: Regel 4.840:
|rpT3a
|rpT3a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT3a
|rpT3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.845: Regel 4.846:
|rpT3b
|rpT3b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT3b
|rpT3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.851: Regel 4.852:
|rpT3c
|rpT3c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT3c
|rpT3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.857: Regel 4.858:
|rpT3d
|rpT3d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT3d
|rpT3d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.863: Regel 4.864:
|rpT4
|rpT4
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT4
|rpT4
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.869: Regel 4.870:
|rpT4a
|rpT4a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT4a
|rpT4a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.875: Regel 4.876:
|rpT4b
|rpT4b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT4b
|rpT4b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.881: Regel 4.882:
|rpT4c
|rpT4c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT4c
|rpT4c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.887: Regel 4.888:
|rpT4d
|rpT4d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT4d
|rpT4d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 4.893: Regel 4.894:
|rpT4e
|rpT4e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|rpT4e
|rpT4e
|}
|}
Regel 5.007: Regel 5.008:
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|UICC 8e editie
|UICC 8e editie
|UICC TNM8
|UICCTNM8
|TNMVersie
|TNMVersie
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8
Regel 5.065: Regel 5.066:
|ycNX
|ycNX
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycNX
|ycNX
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.071: Regel 5.072:
|ycNX(f)
|ycNX(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycNX(f)
|ycNX(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.077: Regel 5.078:
|ycNX(sn)
|ycNX(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycNX(sn)
|ycNX(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.083: Regel 5.084:
|ycN0
|ycN0
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0
|ycN0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.089: Regel 5.090:
|ycN0(f)
|ycN0(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(f)
|ycN0(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.095: Regel 5.096:
|ycN0(sn)
|ycN0(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(sn)
|ycN0(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.101: Regel 5.102:
|ycN0(i-)
|ycN0(i-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i-)
|ycN0(i-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.107: Regel 5.108:
|ycN0(i-)(sn)
|ycN0(i-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i-)(sn)
|ycN0(i-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.113: Regel 5.114:
|ycN0(i+)
|ycN0(i+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i+)
|ycN0(i+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.119: Regel 5.120:
|ycN0(i+)(sn)
|ycN0(i+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i+)(sn)
|ycN0(i+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.125: Regel 5.126:
|ycN0(mol-)
|ycN0(mol-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(mol-)
|ycN0(mol-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.131: Regel 5.132:
|ycN0(mol-)(sn)
|ycN0(mol-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(mol-)(sn)
|ycN0(mol-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.137: Regel 5.138:
|ycN0(mol+)
|ycN0(mol+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(mol+)
|ycN0(mol+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.143: Regel 5.144:
|ycN0(mol+)(sn)
|ycN0(mol+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(mol+)(sn)
|ycN0(mol+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.149: Regel 5.150:
|ycN1
|ycN1
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1
|ycN1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.155: Regel 5.156:
|ycN1(f)
|ycN1(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1(f)
|ycN1(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.161: Regel 5.162:
|ycN1(sn)
|ycN1(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1(sn)
|ycN1(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.167: Regel 5.168:
|ycN1mi
|ycN1mi
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1mi
|ycN1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.173: Regel 5.174:
|ycN1mi(f)
|ycN1mi(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1mi(f)
|ycN1mi(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.179: Regel 5.180:
|ycN1mi(sn)
|ycN1mi(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1mi(sn)
|ycN1mi(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.185: Regel 5.186:
|ycN1a
|ycN1a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1a
|ycN1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.191: Regel 5.192:
|ycN1a(f)
|ycN1a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1a(f)
|ycN1a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.197: Regel 5.198:
|ycN1a(sn)
|ycN1a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1a(sn)
|ycN1a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.203: Regel 5.204:
|ycN1b
|ycN1b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1b
|ycN1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.209: Regel 5.210:
|ycN1b(f)
|ycN1b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1b(f)
|ycN1b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.215: Regel 5.216:
|ycN1b(sn)
|ycN1b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1b(sn)
|ycN1b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.221: Regel 5.222:
|ycN1c
|ycN1c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1c
|ycN1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.227: Regel 5.228:
|ycN1c(f)
|ycN1c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1c(f)
|ycN1c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.233: Regel 5.234:
|ycN1c(sn)
|ycN1c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN1c(sn)
|ycN1c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.239: Regel 5.240:
|ycN2
|ycN2
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2
|ycN2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.245: Regel 5.246:
|ycN2(f)
|ycN2(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2(f)
|ycN2(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.251: Regel 5.252:
|ycN2(sn)
|ycN2(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2(sn)
|ycN2(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.257: Regel 5.258:
|ycN2a
|ycN2a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2a
|ycN2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.263: Regel 5.264:
|ycN2a(f)
|ycN2a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2a(f)
|ycN2a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.269: Regel 5.270:
|ycN2a(sn)
|ycN2a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2a(sn)
|ycN2a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.275: Regel 5.276:
|ycN2b
|ycN2b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2b
|ycN2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.281: Regel 5.282:
|ycN2b(f)
|ycN2b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2b(f)
|ycN2b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.287: Regel 5.288:
|ycN2b(sn)
|ycN2b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2b(sn)
|ycN2b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.293: Regel 5.294:
|ycN2c
|ycN2c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2c
|ycN2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.299: Regel 5.300:
|ycN2c(f)
|ycN2c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN2c(f)
|ycN2c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.305: Regel 5.306:
|ycN2c(sn)
|ycN2c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycNX
|ycN2c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3
|ycN3
|ycN3
|ycN3
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycNX(f)
|ycN3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3(f)
|ycN3(f)
|ycN3(f)
|ycN3(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycNX(sn)
|ycN3(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3(sn)
|ycN3(sn)
|ycN3(sn)
|ycN3(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0
|ycN3(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3a
|ycN3a
|ycN3a
|ycN3a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(f)
|ycN3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3a(f)
|ycN3a(f)
|ycN3a(f)
|ycN3a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(sn)
|ycN3a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3a(sn)
|ycN3a(sn)
|ycN3a(sn)
|ycN3a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i-)
|ycN3a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3b
|ycN3b
|ycN3b
|ycN3b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i-)(sn)
|ycN3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3b(f)
|ycN3b(f)
|ycN3b(f)
|ycN3b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i+)
|ycN3b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3b(sn)
|ycN3b(sn)
|ycN3b(sn)
|ycN3b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(i+)(sn)
|ycN3b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3c
|ycN3c
|ycN3c
|ycN3c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(mol-)
|ycN3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3c(f)
|ycN3c(f)
|ycN3c(f)
|ycN3c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(mol-)(sn)
|ycN3c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|ycN3c(sn)
|ycN3c(sn)
|ycN3c(sn)
|ycN3c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ycN0(mol+)
|ycN3c(sn)
|}
|}
Opm.:<!--vsNotes--> De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).
Opm.:<!--vsNotes--> De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).
Regel 5.397: Regel 5.398:
|ycTx
|ycTx
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTx
|ycTx
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.403: Regel 5.404:
|ycT0
|ycT0
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT0
|ycT0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.409: Regel 5.410:
|ycTa
|ycTa
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTa
|ycTa
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.415: Regel 5.416:
|ycTis
|ycTis
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTis
|ycTis
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.421: Regel 5.422:
|ycTis (DCIS)
|ycTis (DCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTis (DCIS)
|ycTis (DCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.427: Regel 5.428:
|ycTis (LAMN)
|ycTis (LAMN)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTis (LAMN)
|ycTis (LAMN)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.433: Regel 5.434:
|ycTis (LCIS)
|ycTis (LCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTis (LCIS)
|ycTis (LCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.439: Regel 5.440:
|ycTis (Paget)
|ycTis (Paget)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTis (Paget)
|ycTis (Paget)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.445: Regel 5.446:
|ycTis pu
|ycTis pu
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycTis pu
|ycTis pu
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.451: Regel 5.452:
|ycT1
|ycT1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1
|ycT1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.457: Regel 5.458:
|ycT1mi
|ycT1mi
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1mi
|ycT1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.463: Regel 5.464:
|ycT1a
|ycT1a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1a
|ycT1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.469: Regel 5.470:
|ycT1a1
|ycT1a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1a1
|ycT1a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.475: Regel 5.476:
|ycT1a2
|ycT1a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1a2
|ycT1a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.481: Regel 5.482:
|ycT1b
|ycT1b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1b
|ycT1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.487: Regel 5.488:
|ycT1b1
|ycT1b1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1b1
|ycT1b1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.493: Regel 5.494:
|ycT1b2
|ycT1b2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1b2
|ycT1b2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.499: Regel 5.500:
|ycT1c
|ycT1c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1c
|ycT1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.505: Regel 5.506:
|ycT1c1
|ycT1c1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1c1
|ycT1c1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.511: Regel 5.512:
|ycT1c2
|ycT1c2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1c2
|ycT1c2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.517: Regel 5.518:
|ycT1c3
|ycT1c3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1c3
|ycT1c3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.523: Regel 5.524:
|ycT1d
|ycT1d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT1d
|ycT1d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.529: Regel 5.530:
|ycT2
|ycT2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT2
|ycT2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.535: Regel 5.536:
|ycT2a
|ycT2a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT2a
|ycT2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.541: Regel 5.542:
|ycT2a1
|ycT2a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT2a1
|ycT2a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.547: Regel 5.548:
|ycT2a2
|ycT2a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT2a2
|ycT2a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.553: Regel 5.554:
|ycT2b
|ycT2b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT2b
|ycT2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.559: Regel 5.560:
|ycT2c
|ycT2c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT2c
|ycT2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.565: Regel 5.566:
|ycT2d
|ycT2d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT2d
|ycT2d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.571: Regel 5.572:
|ycT3
|ycT3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT3
|ycT3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.577: Regel 5.578:
|ycT3a
|ycT3a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT3a
|ycT3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.583: Regel 5.584:
|ycT3b
|ycT3b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT3b
|ycT3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.589: Regel 5.590:
|ycT3c
|ycT3c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT3c
|ycT3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.595: Regel 5.596:
|ycT3d
|ycT3d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT3d
|ycT3d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.601: Regel 5.602:
|ycT3e
|ycT3e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT3e
|ycT3e
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.607: Regel 5.608:
|ycT4
|ycT4
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT4
|ycT4
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.613: Regel 5.614:
|ycT4a
|ycT4a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT4a
|ycT4a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.619: Regel 5.620:
|ycT4b
|ycT4b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT4b
|ycT4b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.625: Regel 5.626:
|ycT4c
|ycT4c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT4c
|ycT4c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.631: Regel 5.632:
|ycT4d
|ycT4d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT4d
|ycT4d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.637: Regel 5.638:
|ycT4e
|ycT4e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ycT4e
|ycT4e
|}
|}
Regel 5.657: Regel 5.658:
|ypNX
|ypNX
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypNX
|ypNX
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.663: Regel 5.664:
|ypNX(f)
|ypNX(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypNX(f)
|ypNX(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.669: Regel 5.670:
|ypNX(sn)
|ypNX(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypNX(sn)
|ypNX(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.675: Regel 5.676:
|ypN0
|ypN0
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0
|ypN0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.681: Regel 5.682:
|ypN0(f)
|ypN0(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(f)
|ypN0(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.687: Regel 5.688:
|ypN0(sn)
|ypN0(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(sn)
|ypN0(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.693: Regel 5.694:
|ypN0(i-)
|ypN0(i-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(i-)
|ypN0(i-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.699: Regel 5.700:
|ypN0(i-)(sn)
|ypN0(i-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(i-)(sn)
|ypN0(i-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.705: Regel 5.706:
|ypN0(i+)
|ypN0(i+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(i+)
|ypN0(i+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.711: Regel 5.712:
|ypN0(i+)(sn)
|ypN0(i+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(i+)(sn)
|ypN0(i+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.717: Regel 5.718:
|ypN0(mol-)
|ypN0(mol-)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(mol-)
|ypN0(mol-)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.723: Regel 5.724:
|ypN0(mol-)(sn)
|ypN0(mol-)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(mol-)(sn)
|ypN0(mol-)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.729: Regel 5.730:
|ypN0(mol+)
|ypN0(mol+)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(mol+)
|ypN0(mol+)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.735: Regel 5.736:
|ypN0(mol+)(sn)
|ypN0(mol+)(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN0(mol+)(sn)
|ypN0(mol+)(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.741: Regel 5.742:
|ypN1
|ypN1
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1
|ypN1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.747: Regel 5.748:
|ypN1(f)
|ypN1(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1(f)
|ypN1(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.753: Regel 5.754:
|ypN1(sn)
|ypN1(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1(sn)
|ypN1(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.759: Regel 5.760:
|ypN1mi
|ypN1mi
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1mi
|ypN1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.765: Regel 5.766:
|ypN1mi(f)
|ypN1mi(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1mi(f)
|ypN1mi(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.771: Regel 5.772:
|ypN1mi(sn)
|ypN1mi(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1mi(sn)
|ypN1mi(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.777: Regel 5.778:
|ypN1a
|ypN1a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1a
|ypN1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.783: Regel 5.784:
|ypN1a(f)
|ypN1a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1a(f)
|ypN1a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.789: Regel 5.790:
|ypN1a(sn)
|ypN1a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1a(sn)
|ypN1a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.795: Regel 5.796:
|ypN1b
|ypN1b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1b
|ypN1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.801: Regel 5.802:
|ypN1b(f)
|ypN1b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1b(f)
|ypN1b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.807: Regel 5.808:
|ypN1b(sn)
|ypN1b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1b(sn)
|ypN1b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.813: Regel 5.814:
|ypN1c
|ypN1c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1c
|ypN1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.819: Regel 5.820:
|ypN1c(f)
|ypN1c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1c(f)
|ypN1c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.825: Regel 5.826:
|ypN1c(sn)
|ypN1c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN1c(sn)
|ypN1c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.831: Regel 5.832:
|ypN2
|ypN2
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2
|ypN2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.837: Regel 5.838:
|ypN2(f)
|ypN2(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2(f)
|ypN2(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.843: Regel 5.844:
|ypN2(sn)
|ypN2(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2(sn)
|ypN2(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.849: Regel 5.850:
|ypN2a
|ypN2a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2a
|ypN2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.855: Regel 5.856:
|ypN2a(f)
|ypN2a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2a(f)
|ypN2a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.861: Regel 5.862:
|ypN2a(sn)
|ypN2a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2a(sn)
|ypN2a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.867: Regel 5.868:
|ypN2b
|ypN2b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2b
|ypN2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.873: Regel 5.874:
|ypN2b(f)
|ypN2b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2b(f)
|ypN2b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.879: Regel 5.880:
|ypN2b(sn)
|ypN2b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2b(sn)
|ypN2b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.885: Regel 5.886:
|ypN2c
|ypN2c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2c
|ypN2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.891: Regel 5.892:
|ypN2c(f)
|ypN2c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2c(f)
|ypN2c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.897: Regel 5.898:
|ypN2c(sn)
|ypN2c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN2c(sn)
|ypN2c(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.903: Regel 5.904:
|ypN3
|ypN3
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3
|ypN3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.909: Regel 5.910:
|ypN3(f)
|ypN3(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3(f)
|ypN3(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.915: Regel 5.916:
|ypN3(sn)
|ypN3(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3(sn)
|ypN3(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.921: Regel 5.922:
|ypN3a
|ypN3a
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3a
|ypN3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.927: Regel 5.928:
|ypN3a(f)
|ypN3a(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3a(f)
|ypN3a(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.933: Regel 5.934:
|ypN3a(sn)
|ypN3a(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3a(sn)
|ypN3a(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.939: Regel 5.940:
|ypN3b
|ypN3b
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3b
|ypN3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.945: Regel 5.946:
|ypN3b(f)
|ypN3b(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3b(f)
|ypN3b(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.951: Regel 5.952:
|ypN3b(sn)
|ypN3b(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3b(sn)
|ypN3b(sn)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.957: Regel 5.958:
|ypN3c
|ypN3c
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3c
|ypN3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.963: Regel 5.964:
|ypN3c(f)
|ypN3c(f)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3c(f)
|ypN3c(f)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.969: Regel 5.970:
|ypN3c(sn)
|ypN3c(sn)
|N_RegionaleLymfeklieren
|N_RegionaleLymfeklieren
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11
|ypN3c(sn)
|ypN3c(sn)
|}
|}
Regel 5.989: Regel 5.990:
|ypTx
|ypTx
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTx
|ypTx
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 5.995: Regel 5.996:
|ypT0
|ypT0
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT0
|ypT0
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.001: Regel 6.002:
|ypTa
|ypTa
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTa
|ypTa
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.007: Regel 6.008:
|ypTis
|ypTis
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTis
|ypTis
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.013: Regel 6.014:
|ypTis (DCIS)
|ypTis (DCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTis (DCIS)
|ypTis (DCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.019: Regel 6.020:
|ypTis (LAMN)
|ypTis (LAMN)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTis (LAMN)
|ypTis (LAMN)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.025: Regel 6.026:
|ypTis (LCIS)
|ypTis (LCIS)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTis (LCIS)
|ypTis (LCIS)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.031: Regel 6.032:
|ypTis (Paget)
|ypTis (Paget)
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTis (Paget)
|ypTis (Paget)
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.037: Regel 6.038:
|ypTis pu
|ypTis pu
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypTis pu
|ypTis pu
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.043: Regel 6.044:
|ypT1
|ypT1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1
|ypT1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.049: Regel 6.050:
|ypT1mi
|ypT1mi
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1mi
|ypT1mi
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.055: Regel 6.056:
|ypT1a
|ypT1a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1a
|ypT1a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.061: Regel 6.062:
|ypT1a1
|ypT1a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1a1
|ypT1a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.067: Regel 6.068:
|ypT1a2
|ypT1a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1a2
|ypT1a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.073: Regel 6.074:
|ypT1b
|ypT1b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1b
|ypT1b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.079: Regel 6.080:
|ypT1b1
|ypT1b1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1b1
|ypT1b1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.085: Regel 6.086:
|ypT1b2
|ypT1b2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1b2
|ypT1b2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.091: Regel 6.092:
|ypT1c
|ypT1c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1c
|ypT1c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.097: Regel 6.098:
|ypT1c1
|ypT1c1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1c1
|ypT1c1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.103: Regel 6.104:
|ypT1c2
|ypT1c2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1c2
|ypT1c2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.109: Regel 6.110:
|ypT1c3
|ypT1c3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1c3
|ypT1c3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.115: Regel 6.116:
|ypT1d
|ypT1d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT1d
|ypT1d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.121: Regel 6.122:
|ypT2
|ypT2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT2
|ypT2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.127: Regel 6.128:
|ypT2a
|ypT2a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT2a
|ypT2a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.133: Regel 6.134:
|ypT2a1
|ypT2a1
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT2a1
|ypT2a1
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.139: Regel 6.140:
|ypT2a2
|ypT2a2
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT2a2
|ypT2a2
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.145: Regel 6.146:
|ypT2b
|ypT2b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT2b
|ypT2b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.151: Regel 6.152:
|ypT2c
|ypT2c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT2c
|ypT2c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.157: Regel 6.158:
|ypT2d
|ypT2d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT2d
|ypT2d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.163: Regel 6.164:
|ypT3
|ypT3
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT3
|ypT3
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.169: Regel 6.170:
|ypT3a
|ypT3a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT3a
|ypT3a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.175: Regel 6.176:
|ypT3b
|ypT3b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT3b
|ypT3b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.181: Regel 6.182:
|ypT3c
|ypT3c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT3c
|ypT3c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.187: Regel 6.188:
|ypT3d
|ypT3d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT3d
|ypT3d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.193: Regel 6.194:
|ypT4
|ypT4
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT4
|ypT4
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.199: Regel 6.200:
|ypT4a
|ypT4a
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT4a
|ypT4a
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.205: Regel 6.206:
|ypT4b
|ypT4b
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT4b
|ypT4b
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.211: Regel 6.212:
|ypT4c
|ypT4c
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT4c
|ypT4c
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.217: Regel 6.218:
|ypT4d
|ypT4d
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT4d
|ypT4d
|-style="vertical-align:top; "
|-style="vertical-align:top; "
Regel 6.223: Regel 6.224:
|ypT4e
|ypT4e
|T_PrimaireTumor
|T_PrimaireTumor
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10
|ypT4e
|ypT4e
|}
|}
Regel 6.240: Regel 6.241:
Om informatie op basis van zorginformatiebouwstenen uit te wisselen zijn aanvullende, meer technische specificaties nodig.<BR>Niet iedere omgeving kan met dezelfde technische specificaties overweg. Om deze reden zijn er meerdere typen technische specificaties:<!--ftReferenceIntro-->
Om informatie op basis van zorginformatiebouwstenen uit te wisselen zijn aanvullende, meer technische specificaties nodig.<BR>Niet iedere omgeving kan met dezelfde technische specificaties overweg. Om deze reden zijn er meerdere typen technische specificaties:<!--ftReferenceIntro-->
<ul>
<ul>
<li>HL7® versie 3 CDA compatibele specificaties, beschikbaar via de Nictiz ART-DECOR® omgeving<!--ftArtDecorReference--> [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2020bbr-?id=2.16.840.1.113883.2.4.3.11.60.10.4.2.4.27&effectiveDate=2020-09-01T00:00:00&language=nl-NL&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
<li>HL7® versie 3 CDA compatibele specificaties, beschikbaar via de Nictiz ART-DECOR® omgeving<!--ftArtDecorReference--> [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2020bbr-?id=2.16.840.1.113883.2.4.3.11.60.121.4.2.4.27&effectiveDate=2020-09-01T00:00:00&language=nl-NL&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
<li>HL7® FHIR® compatibele specificaties, beschikbaar via de Nictiz-omgeving op de Simplifier FHIR Registry<!--ftSimplifierReference--> {{SimplefierLinks|2020}}</li>
<li>HL7® FHIR® compatibele specificaties, beschikbaar via de Nictiz-omgeving op de Simplifier FHIR Registry<!--ftSimplifierReference--> {{SimplefierLinks|2020}}</li>
</ul>
</ul>
Regel 6.249: Regel 6.250:
SNOMED CT en LOINC codes zijn gebaseeerd op:
SNOMED CT en LOINC codes zijn gebaseeerd op:
<ul>
<ul>
<li>SNOMED Clinical Terms version: 20200309 [R] (March 2020 Interim Release)</li>
<li>SNOMED Clinical Terms version: 20200731 [R] (July 2020 Release)</li>
<li>LOINC version 2.67</li>
<li>LOINC version 2.67</li>
</ul>
</ul>
De voorwaarden van gebruik staan op de beginpagina<!--ftConditions--> [[Bestand:list2.png|link=ZIB_Hoofdpagina<!--wikiMainpage-->]]<BR>
De voorwaarden van gebruik staan op de beginpagina<!--ftConditions--> [[Bestand:list2.png|link=ZIB_Hoofdpagina<!--wikiMainpage-->]]<BR>
Deze pagina is gegenereerd op 05/09/2020 22:12:20 met ZibExtraction v. 4.0.7553.39553<!--ftDate--> <BR>
Deze pagina is gegenereerd op 29/09/2020 22:35:00 met ZibExtraction v. 4.0.7577.31095<!--ftDate--> <BR>
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= ZIB_Publicatie<!--wikiReleasePage-->_2020(NL)]] [[ZIB_Publicatie<!--wikiReleasePage-->_2020(NL) |Terug naar ZIB overzicht<!--hdBackToMainPage--> ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= ZIB_Publicatie<!--wikiReleasePage-->_2020(NL)]] [[ZIB_Publicatie<!--wikiReleasePage-->_2020(NL) |Terug naar ZIB overzicht<!--hdBackToMainPage--> ]]</div>

Huidige versie van 29 sep 2020 om 21:44


Let op!! Dit is niet de meeste recente versie van deze bouwsteen. Deze is ''hier'' te vinden.

Algemeen

Naam: nl.zorg.TNMTumorClassificatie EN.png
Versie: 1.0
ZIB Status:Final
Publicatie: 2020
Publicatie status: Published
Publicatie datum: 01-09-2020

Back 16.png Terug naar ZIB overzicht

Metadata

DCM::CoderList *
DCM::ContactInformation.Address *
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom *
DCM::ContentAuthorList *
DCM::CreationDate 15/05/2020
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name *
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.4.27
DCM::KeywordList
DCM::LifecycleStatus Final
DCM::ModelerList *
DCM::Name nl.zorg.TNMTumorClassificatie
DCM::PublicationDate 01-09-2020
DCM::PublicationStatus Published
DCM::ReviewerList
DCM::RevisionDate
DCM::Supersedes *
DCM::Version 1.0
HCIM::PublicationLanguage NL

Revision History

Publicatieversie 1.0 (01-09-2020).

Concept

TNM Classificatie van Maligne Tumoren (TNM) is het systeem voor de stadiëring van kanker dat is ontwikkeld door de Union Internationale Contre le Cancer of International Union Against Cancer (UICC). De TNM-classificatie wordt ook gebruikt door de American Joint Committee on Cancer (AJCC) en de International Federation of Gynecology and Obstetrics (FIGO). In 1987 werden de TNM-classificaties van de UICC en de AJCC tot één systeem gecombineerd met dezelfde definities. Desondanks zitten er nog altijd verschillen tussen beide systemen.
De TNM-classificatie is ontwikkeld voor solide tumoren (waaronder carcinomen en sarcomen); niet-solide tumoren (bijvoorbeeld lymfomen en gliomen) kennen een ander systeem voor stadiëring. De algemene opzet is als volgt: De T staat voor tumor en beschrijft de grootte van de tumor en de lokale uitbreiding, de N staat voor lymfekliermetastasering (Engels: node) en de M staat voor metastase op afstand (uitbreiding van de kanker van één locatie in het lichaam naar een andere. Naast T, N en M bevat de classificatie nog een aantal andere parameters.

Purpose

TNM-classificatie is een belangrijke bepalende factor voor de juiste behandeling en prognose. Het stadium is een steeds belangrijker onderdeel van kankersurveillance en kankerbestrijding en een eindpunt voor de evaluatie van populatie screening en vroege detectie.
Het TNM-stadiëringssysteem is de gemeenschappelijke taal waarin zorgprofessionals in de oncologie kunnen communiceren over de uitbreiding en verspreiding van kanker bij individuele patiënten als basis voor besluitvorming over behandeling en individuele prognose. Het kan ook worden gebruikt voor het opstellen en evalueren van behandelrichtlijnen, nationale beleid t.a.v. zorgplanning en onderzoek.
De doelstellingen van de TNM-classificatie zijn:

  • Hulp bij het plannen van de behandeling.
  • Het geven van een indicatie van prognose op basis van historische gegevens over uitkomsten.
  • Ondersteuning bij de evaluatie van behandelresultaten.
  • De uitwisseling van informatie tussen behandelcentra vergemakkelijken.
  • Bijdragen aan doorlopend onderzoek naar kanker.
  • Ondersteuning van kankerbestrijding, onder meer via kankerregisters.

De TNM-classificatie is een uniforme standaard. Het doel is breder dan alleen de toepassing binnen het primaire zorgproces en zorgt voor essentiële informatie voor beleidsmakers die kankerbestrijdings- en preventieplannen ontwikkelen of uitvoeren.

Patient Population

Volwassen patiënten met een solide tumor waarop een TNM-classificatie kan worden toegepast.

Information Model


#R ResidueleTumorCodelijst#PrognostischStadiumCodelijst#AnatomischStadiumCodelijst#V VeneuzeInvasieCodelijst#Pn PerineuraleInvasieCodelijst#L LymfatischeInvasieCodelijst#TNMVersieCodelijst#14147#14193#14178#14170#14152#14151#14150#14138#14146#14135#14137#14149#14143#14140TNMTumorClassificatie-v1.0Model(2020NL).png
#aT PrimaireTumorCodelijst#rpT PrimaireTumorCodelijst#rcT PrimaireTumorCodelijst#ypT PrimaireTumorCodelijst#pT PrimaireTumorCodelijst#ycT PrimaireTumorCodelijst#cT PrimaireTumorCodelijst#m AantalPrimaireTumorenCodelijstAnatomischeLocatie-v1.0(2020NL)#G DifferentiatiegraadTumorCodelijst#MorfologieCodelijst#14156#14173#14172#14167#14175#14164#14162#14170PrimaireTumor-v1.0Model(2020NL).png
#aN RegionaleLymfeklierenCodelijst#rpN RegionaleLymfeklierenCodelijst#rcN RegionaleLymfeklierenCodelijst#ypN RegionaleLymfeklierenCodelijst#pN RegionaleLymfeklierenCodelijst#ycN RegionaleLymfeklierenCodelijst#cN RegionaleLymfeklierenCodelijstAnatomischeLocatie-v1.0(2020NL)#14179#14183#14178RegionaleLymfeklieren-v1.0Model(2020NL).png
#aM AfstandsMetastasenCodelijstAnatomischeLocatie-v1.0(2020NL)#14189#14192#14193#cpM AfstandsMetastasenCodelijst#rcrpM AfstandsMetastasenCodelijstAfstandsMetastasen-v1.0Model(2020NL).png


Type Id Concept Card. Definitie DefinitieCode Verwijzing
Block.png NL-CM:4.27.1 Arrowdown.pngTNMTumorClassificatie Rootconcept van de bouwsteen TNMTumorClassificatie. Dit rootconcept bevat alle gegevenselementen van de bouwsteen TNMTumorClassificatie.
385379008 TNM tumor staging finding
Folder.png NL-CM:4.27.25 Arrowdown.pngAfstandsMetastasen 0..1 Container van het concept AfstandsMetastasen. Deze container bevat alle gegevenselementen van het concept AfstandsMetastasen.
385380006 Metastasis category finding
CD.png NL-CM:4.27.26 Arrowright.pngM_AfstandsMetastasen 0..1 Uitkomst van stadiëring van de aan- of afwezigheid van metastasen op afstand, de M-categorie van de TNM classificatie.
277208005 M-categorie van Tumor-Node-Metastasis-classificatie
List2.png aM_AfstandsMetastasenCodelijst
List2.png cpM_AfstandsMetastasenCodelijst
List2.png rcrpM_AfstandsMetastasenCodelijst
Folder.png NL-CM:4.27.27 Arrowdown.pngAfstandsMetastasenLocalisatie 0..* Container van het concept AfstandsMetastasenLocalisatie. Deze container bevat alle gegevenselementen van het concept AfstandsMetastasenLocalisatie.
385421009 Locatie van metastase op afstand
Verwijzing.png NL-CM:4.27.28 Arrowright.pngMetastasen::AnatomischeLocatie 0..1 Het betreft de lokalisatie(s) van de afstandsmetastasen, die aangedaan zijn door de primaire tumor.
385421009 Locatie van metastase op afstand
Block.png AnatomischeLocatie
Folder.png NL-CM:4.27.21 Arrowdown.pngRegionaleLymfeklieren 0..1 Container van het concept RegionaleLymfeklieren. Deze container bevat alle gegevenselementen van het concept RegionaleLymfeklieren.
301855007 Finding of lymph node
CD.png NL-CM:4.27.22 Arrowright.pngN_RegionaleLymfeklieren 0..1 Uitkomst van stadiëring van de aan- of afwezigheid en omvang regionale lymfekliermetastase, de N-categorie van de TNM classificatie.
277206009 N-categorie van tumor-node-metastasis-classificatie
List2.png aN_RegionaleLymfeklierenCodelijst
List2.png cN_RegionaleLymfeklierenCodelijst
List2.png pN_RegionaleLymfeklierenCodelijst
List2.png rcN_RegionaleLymfeklierenCodelijst
List2.png rpN_RegionaleLymfeklierenCodelijst
List2.png ycN_RegionaleLymfeklierenCodelijst
List2.png ypN_RegionaleLymfeklierenCodelijst
Folder.png NL-CM:4.27.23 Arrowdown.pngRegionaleLymfeklierenLocalisatie 0..* Container van het concept RegionaleLymfeklierenLocalisatie. Deze container bevat alle gegevenselementen van het concept RegionaleLymfeklierenLocalisatie.
364108009 Lymph node observable
Verwijzing.png NL-CM:4.27.24 Arrowright.pngLymfeklieren::AnatomischeLocatie 0..1 Het betreft de lokalisatie(s) van de aangedane regionale lymfeklieren door de primaire tumor.
397440000 Locatie van aangedane lymfeklier
Block.png AnatomischeLocatie
Folder.png NL-CM:4.27.12 Arrowdown.pngPrimaireTumor 0..1 Container van het concept PrimaireTumor. Deze container bevat alle gegevenselementen van het concept PrimaireTumor.
86049000 Primaire maligniteit
CD.png NL-CM:4.27.13 Arrowright.pngm_AantalPrimaireTumoren 0..1 Het aantal primaire tumoren. Indien er meerdere primaire tumoren in één orgaan aanwezig zijn wordt de afwijking met de hoogste T-categorie geclassificeerd en de multipliciteit of het aantal primaire tumoren uitgedrukt in een aanvulling op de T-categorie in de vorm van (m) of een (<getal>), bijv. T2(m) of T2(2). Bij één primaire tumor wordt deze weggelaten uit de ‘GeintegreerdeTNMWaardeoverallTNMClassificatie’.
133641000146103 Aantal primaire tumoren
List2.png m_AantalPrimaireTumorenCodelijst
CD.png NL-CM:4.27.14 Arrowright.pngT_PrimaireTumor 0..1 Uitkomst van stadiëring van de omvang van de primaire tumor, de T-categorie inclusief prefix en suffix.
78873005 T-categorie van Tumor-Node-Metastasis-classificatie
List2.png aT_PrimaireTumorCodelijst
List2.png cT_PrimaireTumorCodelijst
List2.png pT_PrimaireTumorCodelijst
List2.png rcT_PrimaireTumorCodelijst
List2.png rpT_PrimaireTumorCodelijst
List2.png ycT_PrimaireTumorCodelijst
List2.png ypT_PrimaireTumorCodelijst
Folder.png NL-CM:4.27.15 Arrowdown.pngAfwijking 1..* Container van het concept Afwijking. Deze container bevat alle gegevenselementen van het concept Afwijking.
108369006 Neoplasma
INT.png NL-CM:4.27.16 Arrowright.pngAfwijkingNummer 0..1 Het aan de afwijking toegewezen nummer, noodzakelijk om bij verschillende onderzoeken eenduidig aan te kunnen geven op welke afwijking de informatie betrekking heeft .

Bij meerdere afwijkingen in één orgaan wordt de afwijking met de hoogste T-categorie geclassificeerd.

CD.png NL-CM:4.27.17 Arrowright.pngMorfologie 0..1 Gedrag van de tumor en het celtype van de tumor uitgedrukt in de ICD-O-3 morfologie code. Beschrijft het celtype of histologie van de tumor als ook het gedrag van die cel (maligne of benigne).

Deze wordt door een patholoog bepaald.

396984004 Histologic feature of tumor
List2.png MorfologieCodelijst
CD.png NL-CM:4.27.18 Arrowright.pngG_DifferentiatiegraadTumor 0..1 Uitkomst van stadiëring van de G-categorie, de differentiatiegraad van de tumor, die door een patholoog wordt bepaald.
371469007 Histologic grade
List2.png G_DifferentiatiegraadTumorCodelijst
Folder.png NL-CM:4.27.19 Arrowdown.pngTumorLokalisatie 0..* Container van het concept TumorLokalisatie. Deze container bevat alle gegevenselementen van het concept TumorLokalisatie.
399687005 Locatie van primaire tumor
Verwijzing.png NL-CM:4.27.20 Arrowright.pngTumor::AnatomischeLocatie 0..1 Het betreft de lokalisatie van de primaire tumor(en), welke (o.a.) bepalend is voor het toekennen van de TNM-classificatie aan de tumor.
399687005 Locatie van primaire tumor
Block.png AnatomischeLocatie
TS.png NL-CM:4.27.2 Arrowright.pngDatumTNMClassificatie 0..1 De datum waarop de TNM-Classificatie (de waarde) is vastgesteld.
399651003 Date of report
CD.png NL-CM:4.27.3 Arrowright.pngTNMVersie 0..1 TNM-classificatie versie (AJCC of UICC) en de gebruikte editie (7e, 8e etc.).
273249006 Assessment scales
List2.png TNMVersieCodelijst
ST.png NL-CM:4.27.4 Arrowright.pngGeintegreerdeTNMWaarde 0..1 De vastgestelde TNM-classificatie (de waarde), op basis van elke T-, N- en M-categorie (evt. incl. het aantal primaire tumoren (m) en/of de lokalisatie van M).
399703000 Integrated TNM category
ST.png NL-CM:4.27.5 Arrowright.pngToelichting 0..1 Toelichting met betrekking tot de interpretatie van de geïntegreerde TNM waarde zoals deze is geclassificeerd.
243814003 Interpretation of findings
CD.png NL-CM:4.27.6 Arrowright.pngL_LymfatischeInvasie 0..1 De aan- of afwezigheid van lymfatische invasie, de L-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.
395715009 Status of lymphatic (small vessel) invasion by tumor
List2.png L_LymfatischeInvasieCodelijst
CD.png NL-CM:4.27.7 Arrowright.pngPn_PerineuraleInvasie 0..1 De aan- of afwezigheid van perineurale invasie, de Pn-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.
371513001 Status of perineural invasion by tumor
List2.png Pn_PerineuraleInvasieCodelijst
CD.png NL-CM:4.27.8 Arrowright.pngV_VeneuzeInvasie 0..1 De aan- of afwezigheid van veneuze invasie, de V-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.
371493002 Status of venous (large vessel) invasion by tumor
List2.png V_VeneuzeInvasieCodelijst
CD.png NL-CM:4.27.9 Arrowright.pngAnatomischStadium 0..1 Het stadium van de ziekte is de groepering op basis van de anatomische uitbreiding en verspreiding van de ziekte (de T, N en M categorieën).
399390009 TNM stage grouping
List2.png AnatomischStadiumCodelijst
CD.png NL-CM:4.27.10 Arrowright.pngPrognostischStadium 0..1 Het prognostisch stadium van de ziekte. Hierin wordt in de groepering naast de anatomische uitbreiding en verspreiding van de ziekte ook additionele prognostische factoren meegenomen.
399390009 TNM stage grouping
List2.png PrognostischStadiumCodelijst
CD.png NL-CM:4.27.11 Arrowright.pngR_ResidueleTumor 0..1 De aan- of afwezigheid van residuele tumor na behandeling, de R-categorie.
17964000 Residual tumor stage
List2.png R_ResidueleTumorCodelijst

Kolommen Concept en DefinitieCode: houdt de muis boven de waarde voor meer informatie
Voor uitleg over de gebruikte symbolen, zie de legenda pagina List2.png

Example Instances

TNMTumorClassificatie
datumTNMClassificatie TNMVersie Geintegreerde TNMWaarde
01/08/2020 AJCC 8e editie cT3N2M1
AnatomischStadium PrognostischStadium R_ResidueleTumor
Stage IV Stage IV --
Opmerking HER2 negatief, ER negatief, PR negatief
L_LymfatischeInvasie Pn_PerineuraleInvasie V_VeneuzeInvasie
-- -- --
Primaire Tumor
m_PrimaireTumorAantal T_tumor G_DifferentiatiegraadTumor
1 cT3 G2
Afwijking
AfwijkingNummer Morfologie (ICD-O-3)
1 Infiltrerend ductaal carcinoom, (8500/3)
TumorLokalisatie - AnatomischeLocatie
Locatie ICD-O-3 Locatie SNOMED CT Lateraliteit
(C50.5) Laterale onderkwadrant van borst structuur van laterale onderkwadrant van mamma (33564002) Rechts
AfwijkingNummer Morfologie (ICD-O-3)
2 Fibroadenoom (9010/0)
Regionale Lymfeklieren
N_RegionaleLymfeklieren cN2
RegionaleLymfeklieren Localisatie - AnatomischeLocatie
Locatie ICD-O-3 Locatie Lateraliteit
C77.3 Infraclaviculaire lymfeklier structuur van infraclaviculaire lymfeklier (9659009) Rechts
RegionaleLymfeklieren Localisatie - AnatomischeLocatie
Locatie ICD-O-3 Locatie Lateraliteit
C77.3 Axillaire lymfeklier structuur van nodus lymphoideus axillaris (68171009) Rechts
AfstandsMetastasen
M_Afstandsmetastasen cM1
AfstandsMetastasen Lokalisatie
 Locatie (ICD-O-3) Locatie Lateraliteit
C34.1 Bovenkwab van long Structuur van lobus superior pulmonis (45653009) Rechts

Instructions

Van een generieke TNM classificatie naar een ziekte specifieke TNM classificatie
Bij het uitwerken van een tumor specifieke TNM-bouwsteen of implementatie moet gekeken worden hoe de waardelijsten kunnen worden ingeperkt, toegepast of uitgebreid.
Inperken wil zeggen dat items in een codelijst worden weggelaten of specifiek worden gemaakt door binnen het voorgeschreven code systeem andere termen te kiezen. Het is de bedoeling dat in de toekomst kant en klare codelijsten per kankeraandoening beschikbaar worden gemaakt (zie ook issues).
Codesystemen
In deze zib worden 2 internationale codesystemen gebruikt:

  • SNOMED CT (beheerder international SNOMED international, Nederlands beheer door Nictiz)
  • International Classification of Diseases for Oncology, version 3 (ICD-O-3) beheerd door de WHO.

Waar toepassing van één van deze codesystemen niet zinvol werd geacht of mogelijk was is gekozen voor beheer ervan als onderdeel van het beheer van de zibs. Wanneer er een eenduidige internationale verwijzing mogelijk is naar de TNM standaard zelf als codesysteem met waardelijsten kunnen deze worden aangepast in een volgende versie van de zib.
Uitgangspunten vanuit de TNM standaard

  • Eén TNM-classificatie per orgaan, maar in geval van gepaarde organen is er één classificatie per zijde. Bijvoorbeeld bij borstkanker met in iedere borst een primaire tumor zijn er dan dus ook twee instantiaties van de zib, waarbij de ene lateraliteit links en de andere lateraliteit rechts heeft (beiderzijds is niet toegestaan bij gepaarde organen).
  • Niet alleen de uitkomst van de TNM, maar ook de exacte lokalisatie van de primaire tumor(en), positieve lymfeklieren en metastasen kan worden aangeduid.
  • In het geval van meerdere primaire tumoren in één orgaan, moet de tumor met de hoogste T-categorie worden geclassificeerd en moet de veelvoud of het aantal tumoren tussen haakjes worden vermeld, bijvoorbeeld T2 (m) of T2 (5).De afwijking met de hoogste T-categorie bepaalt de classificatie van de tumor. Om het onderscheid hierin te maken en alle afwijkingen te kunnen weergeven bestaat de container ‘afwijking’ in de zib. Elke afwijking heeft een nummer. Welke afwijking (b.v. 1, 2 of 4) de hoogste t-categorie heeft wordt niet in de zib aangegeven. Dit is logische want dit is pas duidelijk na de inschatting van de zorgverlener o.b.v. de pathologie dan wel beeldvorming.

Gebruikte versie van de UICC / AJCC TNM Classification of Malignant Tumours.

  • Hoewel er geen verschillen in definities en verwoordingen tussen AJCC en UICC TNM classificaties zouden mogen voorkomen zijn er helaas wel enkele verschillen ingeslopen (bijvoorbeeld bij de definitie van regionale lymfeklieren bij slokdarm- en endometriumcarcinomen). Daarom kan in deze zib gekozen worden tussen de UICC en AJCC versie. Criteria die in het TNM-classificatiesysteem worden gebruikt, zijn in de loop van de jaren veranderd en er zijn verschillende edities uitgebracht. Als gevolg hiervan kan een bepaalde stagering een heel andere prognose hebben, afhankelijk van welke editie wordt gebruikt. Verder is een belangrijke overweging het effect van een verbeterde behandeling in de tijd
  • Naast de stagering via UICC of AJCC classificaties is er ook ‘Essential TNM’. Dit is een versimpelde vorm van TNM die is gemaakt voor het weergeven van het voorkomen van kanker in lage lonen landen. In deze landen zijn vaak de middelen voor vroege diagnose niet aanwezig en het gebruik van TNM beperkt (kanker wordt in de regel in deze landen pas in een zeer laat stadium ontdekt). Deze speciale TNM is niet meegenomen in de uitwerking van deze zib. Overigens wordt deze speciale TNM meestal alleen gebruikt voor het kunnen betrekken van deze landen in de statistiek over het voorkomen van bepaalde kankers in deze landen.

Prefix en suffix zijn geïntegreerd in codelijsten. Alhoewel het mogelijk zou zijn om voor de mogelijke voor en achtervoegsels op zowel de T, N en M losse codelijsten te maken is voor het eenvoudig toepassen ervan gekozen om deze te integreren in de codelijsten. Dit is besloten omdat de huidige inzichten zijn dat hiermee het maken van verkeerde combinaties wordt voorkomen
Prefix

  • c: Klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken.
  • yc: Classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).
  • p: De post-chirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.
  • yp: Classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).
  • rc: Klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).
  • rp: Post-operatieve pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).
  • a: Classificatie vastgesteld tijdens autopsie

Suffix

  • (mi): Gevallen met alleen micrometastase
  • (sn): Gevallen waarbij schildwachtklier onderzoek heeft plaatsgevonden.
  • (f): Gevallen waarbij FNA of biopsie heeft plaatsgevonden op de regionale lymfeklieren
  • (i-): negatieve morfologische bevindingen voor geïsoleerde tumorcellen
  • (i+): positieve morfologische bevindingen voor geïsoleerde tumorcellen
  • (mol-): negatieve niet-morfologische bevindingen voor geïsoleerde tumorcellen
  • (mol+): positieve niet- morfologische bevindingen voor geïsoleerde tumorcellen
  • (0): zonder verhoogd lactaatdehydrogenase (LDH)
  • (1): met verhoogd lactaatdehydrogenase (LDH)

Issues

Bruikbaarheid van deze zib als ook de ziekte specifieke codelijsten worden gemaakt in de eerste proeftuin(en), gepland in de zomer van 2020. Gedurende dit project zal IKNL het beheer voor deze codelijsten verzorgen. Wanneer deze proeftuin(en) zijn afgerond worden de bevindingen meegenomen als wijzigingsverzoeken in het reguliere beheerproces van het zib centrum.

References

  1. TNM Classification of Malignant Tumours, 8th Edition - James D. Brierley (Editor), Mary K. Gospodarowicz (Editor), Christian Wittekind (Editor)- International Union Against Cancer (UICC)- ISBN: 9781119263562 (epub)
  2. https://www.uicc.org/resources/tnm [ONLINE geraadpleegd: 04 mei 2020]
  3. International Classification of diseases for oncology (ICD-O) – 3rd edition, 1st revision – April Frits, Constance Percy, Andrew Jack, Kanagaratnam Shanmugaratnam, Leslie Sobin, D Max Parkin, Sharon Whelan – World Health Organisation – WHO library cataloguing – ISBN 978 92 4 069212 1 (PDF)

Valuesets

aM_AfstandsMetastasenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.25 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
aM0 aM0 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM0
aM0(i+) aM0(i+) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM0(i+)
aM0(mol+) aM0(mol+) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM0(mol+)
aM1 aM1 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1
aM1a aM1a M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1a
aM1a(0) aM1a(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1a(0)
aM1a(1) aM1a(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1a(1)
aM1b aM1b M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1b
aM1b(0) aM1b(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1b(0)
aM1b(1) aM1b(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1b(1)
aM1c aM1c M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1c
aM1c(0) aM1c(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1c(0)
aM1c(1) aM1c(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1c(1)
aM1d aM1d M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1d
aM1d(0) aM1d(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1d(0)
aM1d(1) aM1d(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 aM1d(1)

Opm.: De uitbreiding naar metastase op afstand voor een classificatie vastgesteld tijdens autopsie.

aN_RegionaleLymfeklierenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.24 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
aNX aNX N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aNX
aNX(f) aNX(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aNX(f)
aNX(sn) aNX(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aNX(sn)
aN0 aN0 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0
aN0(f) aN0(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(f)
aN0(sn) aN0(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(sn)
aN0(i-) aN0(i-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(i-)
aN0(i-)(sn) aN0(i-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(i-)(sn)
aN0(i+) aN0(i+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(i+)
aN0(i+)(sn) aN0(i+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(i+)(sn)
aN0(mol-) aN0(mol-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(mol-)
aN0(mol-)(sn) aN0(mol-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(mol-)(sn)
aN0(mol+) aN0(mol+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(mol+)
aN0(mol+)(sn) aN0(mol+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN0(mol+)(sn)
aN1 aN1 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1
aN1(f) aN1(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1(f)
aN1(sn) aN1(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1(sn)
aN1mi aN1mi N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1mi
aN1mi(f) aN1mi(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1mi(f)
aN1mi(sn) aN1mi(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1mi(sn)
aN1a aN1a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1a
aN1a(f) aN1a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1a(f)
aN1a(sn) aN1a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1a(sn)
aN1b aN1b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1b
aN1b(f) aN1b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1b(f)
aN1b(sn) aN1b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1b(sn)
aN1c aN1c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1c
aN1c(f) aN1c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1c(f)
aN1c(sn) aN1c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN1c(sn)
aN2 aN2 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2
aN2(f) aN2(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2(f)
aN2(sn) aN2(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2(sn)
aN2a aN2a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2a
aN2a(f) aN2a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2a(f)
aN2a(sn) aN2a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2a(sn)
aN2b aN2b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2b
aN2b(f) aN2b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2b(f)
aN2b(sn) aN2b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2b(sn)
aN2c aN2c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2c
aN2c(f) aN2c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2c(f)
aN2c(sn) aN2c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN2c(sn)
aN3 aN3 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3
aN3(f) aN3(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3(f)
aN3(sn) aN3(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3(sn)
aN3a aN3a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3a
aN3a(f) aN3a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3a(f)
aN3a(sn) aN3a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3a(sn)
aN3b aN3b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3b
aN3b(f) aN3b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3b(f)
aN3b(sn) aN3b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3b(sn)
aN3c aN3c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3c
aN3c(f) aN3c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3c(f)
aN3c(sn) aN3c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 aN3c(sn)

Opm.: De regionale lymfeklieren (N) voor een classificatie vastgesteld tijdens autopsie

AnatomischStadiumCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.1 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
Stadium 0 Stage0 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium 0
Stadium I StageI AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium I
Stadium IA StageIA AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IA
Stadium IA1 StageIA1 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IA1
Stadium IA2 StageIA2 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IA2
Stadium IA3 StageIA3 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IA3
Stadium IC StageIC AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IC
Stadium IB StageIB AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IB
Stadium IB1 StageIB1 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IB1
Stadium IB2 StageIB2 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IB2
Stadium IS StageIs AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IS
Stadium II StageII AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium II
Stadium IIA StageIIA AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIA
Stadium IIA1 StageIIA1 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIA1
Stadium IIA2 StageIIA2 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIA2
Stadium IIB StageIIB AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIB
Stadium IIC StageIIC AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIC
Stadium III StageIII AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium III
Stadium IIIA StageIIIA AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIIA
Stadium IIIA1 StageIIIA1 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIIA1
Stadium IIIA2 StageIIIA2 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIIA2
Stadium IIIB StageIIIB AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIIB
Stadium IIIC StageIIIC AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIIC
Stadium IIIC1 StageIIIC1 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIIC1
Stadium IIIC2 StageIIIC2 AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIIC2
Stadium IIID StageIIID AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IIID
Stadium IV StageIV AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IV
Stadium IVA StageIVA AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IVA
Stadium IVB StageIVB AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IVB
Stadium IVC StageIVC AnatomischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.6 Stadium IVC

aT_PrimaireTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.15 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
aTx aTx T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTx
aT0 aT0 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT0
aTa aTa T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTa
aTis aTis T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTis
aTis (DCIS) aTis (DCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTis (DCIS)
aTis (LAMN) aTis (LAMN) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTis (LAMN)
aTis (LCIS) aTis (LCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTis (LCIS)
aTis (Paget) aTis (Paget) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTis (Paget)
aTis pu aTis pu T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aTis pu
aT1 aT1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1
aT1mi aT1mi T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1mi
aT1a aT1a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1a
aT1a1 aT1a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1a1
aT1a2 aT1a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1a2
aT1b aT1b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1b
aT1b1 aT1b1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1b1
aT1b2 aT1b2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1b2
aT1c aT1c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1c
aT1c1 aT1c1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1c1
aT1c2 aT1c2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1c2
aT1c3 aT1c3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1c3
aT1d aT1d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT1d
aT2 aT2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT2
aT2a aT2a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT2a
aT2a1 aT2a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT2a1
aT2a2 aT2a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT2a2
aT2b aT2b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT2b
aT2c aT2c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT2c
aT2d aT2d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT2d
aT3 aT3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT3
aT3a aT3a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT3a
aT3b aT3b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT3b
aT3c aT3c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT3c
aT3d aT3d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT3d
aT3e aT3e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT3e
aT4 aT4 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT4
aT4a aT4a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT4a
aT4b aT4b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT4b
aT4c aT4c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT4c
aT4d aT4d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT4d
aT4e aT4e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 aT4e

Opm.: De primaire tumor (T) voor een classificatie vastgesteld tijdens autopsie.

cN_RegionaleLymfeklierenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.18 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
cNX cNX N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cNX
cNX(f) cNX(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cNX(f)
cNX(sn) cNX(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cNX(sn)
cN0 cN0 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0
cN0(f) cN0(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(f)
cN0(sn) cN0(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(sn)
cN0(i-) cN0(i-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(i-)
cN0(i-)(sn) cN0(i-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(i-)(sn)
cN0(i+) cN0(i+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(i+)
cN0(i+)(sn) cN0(i+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(i+)(sn)
cN0(mol-) cN0(mol-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(mol-)
cN0(mol-)(sn) cN0(mol-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(mol-)(sn)
cN0(mol+) cN0(mol+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(mol+)
cN0(mol+)(sn) cN0(mol+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN0(mol+)(sn)
cN1 cN1 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1
cN1(f) cN1(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1(f)
cN1(sn) cN1(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1(sn)
cN1mi cN1mi N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1mi
cN1mi(f) cN1mi(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1mi(f)
cN1mi(sn) cN1mi(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1mi(sn)
cN1a cN1a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1a
cN1a(f) cN1a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1a(f)
cN1a(sn) cN1a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1a(sn)
cN1b cN1b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1b
cN1b(f) cN1b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1b(f)
cN1b(sn) cN1b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1b(sn)
cN1c cN1c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1c
cN1c(f) cN1c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1c(f)
cN1c(sn) cN1c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN1c(sn)
cN2 cN2 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2
cN2(f) cN2(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2(f)
cN2(sn) cN2(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2(sn)
cN2a cN2a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2a
cN2a(f) cN2a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2a(f)
cN2a(sn) cN2a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2a(sn)
cN2b cN2b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2b
cN2b(f) cN2b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2b(f)
cN2b(sn) cN2b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2b(sn)
cN2c cN2c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2c
cN2c(f) cN2c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2c(f)
cN2c(sn) cN2c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN2c(sn)
cN3 cN3 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3
cN3(f) cN3(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3(f)
cN3(sn) cN3(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3(sn)
cN3a cN3a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3a
cN3a(f) cN3a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3a(f)
cN3a(sn) cN3a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3a(sn)
cN3b cN3b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3b
cN3b(f) cN3b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3b(f)
cN3b(sn) cN3b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3b(sn)
cN3c cN3c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3c
cN3c(f) cN3c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3c(f)
cN3c(sn) cN3c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 cN3c(sn)

Opm.: De regionale lymfeklieren (N) voor een klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken.

cpM_AfstandsMetastasenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.28 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
cM0 cM0 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM0
cM0(i+) cM0(i+) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM0(i+)
cM0(mol+) cM0(mol+) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM0(mol+)
cM1 cM1 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1
cM1a cM1a M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1a
cM1a(0) cM1a(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1a(0)
cM1a(1) cM1a(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1a(1)
cM1b cM1b M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1b
cM1b(0) cM1b(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1b(0)
cM1b(1) cM1b(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1b(1)
cM1c cM1c M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1c
cM1c(0) cM1c(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1c(0)
cM1c(1) cM1c(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1c(1)
cM1d cM1d M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1d
cM1d(0) cM1d(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1d(0)
cM1d(1) cM1d(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 cM1d(1)
pM1 pM1 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1
pM1a pM1a M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1a
pM1a(0) pM1a(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1a(0)
pM1a(1) pM1a(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1a(1)
pM1b pM1b M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1b
pM1b(0) pM1b(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1b(0)
pM1b(1) pM1b(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1b(1)
pM1c pM1c M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1c
pM1c(0) pM1c(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1c(0)
pM1c(1) pM1c(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1c(1)
pM1d pM1d M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1d
pM1d(0) pM1d(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1d(0)
pM1d(1) pM1d(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 pM1d(1)

Opm.: De uitbreiding naar metastase op afstand (M) voor een klinische of postchirurgische histologische pathologische classificatie.

cT_PrimaireTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.9 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
cTx cTx T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTx
cT0 cT0 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT0
cTa cTa T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTa
cTis cTis T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTis
cTis (DCIS) cTis (DCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTis (DCIS)
cTis (LAMN) cTis (LAMN) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTis (LAMN)
cTis (LCIS) cTis (LCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTis (LCIS)
cTis (Paget) cTis (Paget) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTis (Paget)
cTis pu cTis pu T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cTis pu
cT1 cT1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1
cT1mi cT1mi T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1mi
cT1a cT1a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1a
cT1a1 cT1a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1a1
cT1a2 cT1a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1a2
cT1b cT1b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1b
cT1b1 cT1b1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1b1
cT1b2 cT1b2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1b2
cT1c cT1c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1c
cT1c1 cT1c1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1c1
cT1c2 cT1c2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1c2
cT1c3 cT1c3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1c3
cT1d cT1d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT1d
cT2 cT2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT2
cT2a cT2a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT2a
cT2a1 cT2a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT2a1
cT2a2 cT2a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT2a2
cT2b cT2b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT2b
cT2c cT2c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT2c
cT2d cT2d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT2d
cT3 cT3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT3
cT3a cT3a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT3a
cT3b cT3b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT3b
cT3c cT3c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT3c
cT3d cT3d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT3d
cT3e cT3e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT3e
cT4 cT4 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT4
cT4a cT4a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT4a
cT4b cT4b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT4b
cT4c cT4c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT4c
cT4d cT4d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT4d
cT4e cT4e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 cT4e

Opm.: De primaire tumor (T) voor een klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken

G_DifferentiatiegraadTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.17 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
GX GX G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Differentiatiegraad kan niet beoordeeld worden.
G1 G1 G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Goed gedifferentieerd.
G2 G2 G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Matig gedifferentieerd.
G3 G3 G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Slecht gedifferentieerd.
G3-4 G3-4 G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Slecht gedifferentieerd of ongedifferentieerd.
G4 G4 G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Ongedifferentieerd.
G5 G5 G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Differentiatiegraad groep 5 (Gleason score: 9-10)
LowMitoticRate LowMitoticRate G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Lage mitotische rato
HighMitoticRate HighMitoticRate G_DifferentiatiegraadTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.5 Hoge mitotische rato

L_LymfatischeInvasieCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.2 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
LX LX L_LymfatischeInvasie 2.16.840.1.113883.2.4.3.11.60.40.4.10.9 Aanwezigheid van Lymfatische invasie kan niet beoordeeld worden
L0 L0 L_LymfatischeInvasie 2.16.840.1.113883.2.4.3.11.60.40.4.10.9 Geen Lymfatische invasie
L1 L1 L_LymfatischeInvasie 2.16.840.1.113883.2.4.3.11.60.40.4.10.9 Lymfatische invasie

m_AantalPrimaireTumorenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.8 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
(m) (m) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 Meerdere primaire tumoren
(1) (1) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 1 primaire tumor
(2) (2) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 2 primaire tumoren
(3) (3) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 3 primaire tumoren
(4) (4) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 4 primaire tumoren
(5) (5) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 5 primaire tumoren
(6) (6) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 6 primaire tumoren
(7) (7) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 7 primaire tumoren
(8) (8) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 8 primaire tumoren
(9) (9) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 9 primaire tumoren
(10) (10) m_AantalPrimaireTumoren 2.16.840.1.113883.2.4.3.11.60.40.4.10.12 10 primaire tumoren
Other OTH NullFlavor 2.16.840.1.113883.5.1008 Anders, specificeer.

MorfologieCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.16 Binding: Extensible
Conceptnaam Codestelselnaam Codesysteem OID
International Classification of Diseases for Oncology, version 3 (Morphology codes) ICD-O-3 2.16.840.1.113883.6.43.1

Pn_PerineuraleInvasieCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.3 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
PnX PnX Pn_PerineuraleInvasie 2.16.840.1.113883.2.4.3.11.60.40.5.1.3 Aanwezigheid van Perineurale invasie kan niet beoordeeld worden
Pn0 Pn0 Pn_PerineuraleInvasie 2.16.840.1.113883.2.4.3.11.60.40.5.1.3 Geen Perineurale invasie
Pn1 Pn1 Pn_PerineuraleInvasie 2.16.840.1.113883.2.4.3.11.60.40.5.1.3 Perineurale invasie

pN_RegionaleLymfeklierenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.20 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
pNX pNX N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pNX
pNX(f) pNX(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pNX(f)
pNX(sn) pNX(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pNX(sn)
pN0 pN0 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0
pN0(f) pN0(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(f)
pN0(sn) pN0(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(sn)
pN0(i-) pN0(i-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(i-)
pN0(i-)(sn) pN0(i-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(i-)(sn)
pN0(i+) pN0(i+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(i+)
pN0(i+)(sn) pN0(i+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(i+)(sn)
pN0(mol-) pN0(mol-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(mol-)
pN0(mol-)(sn) pN0(mol-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(mol-)(sn)
pN0(mol+) pN0(mol+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(mol+)
pN0(mol+)(sn) pN0(mol+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN0(mol+)(sn)
pN1 pN1 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1
pN1(f) pN1(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1(f)
pN1(sn) pN1(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1(sn)
pN1mi pN1mi N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1mi
pN1mi(f) pN1mi(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1mi(f)
pN1mi(sn) pN1mi(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1mi(sn)
pN1a pN1a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1a
pN1a(f) pN1a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1a(f)
pN1a(sn) pN1a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1a(sn)
pN1b pN1b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1b
pN1b(f) pN1b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1b(f)
pN1b(sn) pN1b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1b(sn)
pN1c pN1c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1c
pN1c(f) pN1c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1c(f)
pN1c(sn) pN1c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN1c(sn)
pN2 pN2 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2
pN2(f) pN2(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2(f)
pN2(sn) pN2(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2(sn)
pN2a pN2a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2a
pN2a(f) pN2a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2a(f)
pN2a(sn) pN2a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2a(sn)
pN2b pN2b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2b
pN2b(f) pN2b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2b(f)
pN2b(sn) pN2b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2b(sn)
pN2c pN2c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2c
pN2c(f) pN2c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2c(f)
pN2c(sn) pN2c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN2c(sn)
pN3 pN3 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3
pN3(f) pN3(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3(f)
pN3(sn) pN3(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3(sn)
pN3a pN3a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3a
pN3a(f) pN3a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3a(f)
pN3a(sn) pN3a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3a(sn)
pN3b pN3b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3b
pN3b(f) pN3b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3b(f)
pN3b(sn) pN3b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3b(sn)
pN3c pN3c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3c
pN3c(f) pN3c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3c(f)
pN3c(sn) pN3c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 pN3c(sn)

Opm.: De uitbreiding naar regionale lymfeklieren (N) voor een postchirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.

PrognostischStadiumCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.4 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
Stadium 0 Stage0 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium 0
Stadium I StageI PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium I
Stadium IA StageIA PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IA
Stadium IA1 StageIA1 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IA1
Stadium IA2 StageIA2 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IA2
Stadium IA3 StageIA3 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IA3
Stadium IC StageIC PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IC
Stadium IB StageIB PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IB
Stadium IB1 StageIB1 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IB1
Stadium IB2 StageIB2 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IB2
Stadium IS StageIS PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IS
Stadium II StageII PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium II
Stadium IIA StageIIA PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIA
Stadium IIA1 StageIIA1 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIA1
Stadium IIA2 StageIIA2 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIA2
Stadium IIB StageIIB PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIB
Stadium IIC StageIIC PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIC
Stadium III StageIII PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium III
Stadium IIIA StageIIIA PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIIA
Stadium IIIA1 StageIIIA1 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIIA1
Stadium IIIA2 StageIIIA2 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIIA2
Stadium IIIB StageIIIB PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIIB
Stadium IIIC StageIIIC PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIIC
Stadium IIIC1 StageIIIC1 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIIC1
Stadium IIIC2 StageIIIC2 PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIIC2
Stadium IIID StageIIID PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IIID
Stadium IV StageIV PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IV
Stadium IVA StageIVA PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IVA
Stadium IVB StageIVB PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IVB
Stadium IVC StageIVC PrognostischStadium 2.16.840.1.113883.2.4.3.11.60.40.4.10.7 Stadium IVC

pT_PrimaireTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.11 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
pTx pTx T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTx
pT0 pT0 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT0
pTa pTa T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTa
pTis pTis T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTis
pTis (DCIS) pTis (DCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTis (DCIS)
pTis (LAMN) pTis (LAMN) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTis (LAMN)
pTis (LCIS) pTis (LCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTis (LCIS)
pTis (Paget) pTis (Paget) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTis (Paget)
pTis pu pTis pu T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pTis pu
pT1 pT1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1
pT1mi pT1mi T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1mi
pT1a pT1a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1a
pT1a1 pT1a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1a1
pT1a2 pT1a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1a2
pT1b pT1b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1b
pT1b1 pT1b1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1b1
pT1b2 pT1b2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1b2
pT1c pT1c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1c
pT1c1 pT1c1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1c1
pT1c2 pT1c2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1c2
pT1c3 pT1c3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1c3
pT1d pT1d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT1d
pT2 pT2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT2
pT2a pT2a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT2a
pT2a1 pT2a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT2a1
pT2a2 pT2a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT2a2
pT2b pT2b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT2b
pT2c pT2c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT2c
pT2d pT2d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT2d
pT3 pT3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT3
pT3a pT3a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT3a
pT3b pT3b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT3b
pT3c pT3c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT3c
pT3d pT3d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT3d
pT4 pT4 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT4
pT4a pT4a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT4a
pT4b pT4b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT4b
pT4c pT4c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT4c
pT4d pT4d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT4d
pT4e pT4e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 pT4e

Opm.: De primaire tumor (T) voor een post chirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.

R_ResidueleTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.5 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
RX RX R_ResidueleTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.4 Aanwezigheid van residuele tumor kan niet beoordeeld worden
R0 R0 R_ResidueleTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.4 Geen residuele tumor
R1 R1 R_ResidueleTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.4 Microscopische residuele tumor
R2 R2 R_ResidueleTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.4 Macroscopische residuele tumor

rcN_RegionaleLymfeklierenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.22 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
rcNX rcNX N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcNX
rcNX(f) rcNX(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcNX(f)
rcNX(sn) rcNX(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcNX(sn)
rcN0 rcN0 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0
rcN0(f) rcN0(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(f)
rcN0(sn) rcN0(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(sn)
rcN0(i-) rcN0(i-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(i-)
rcN0(i-)(sn) rcN0(i-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(i-)(sn)
rcN0(i+) rcN0(i+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(i+)
rcN0(i+)(sn) rcN0(i+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(i+)(sn)
rcN0(mol-) rcN0(mol-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(mol-)
rcN0(mol-)(sn) rcN0(mol-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(mol-)(sn)
rcN0(mol+) rcN0(mol+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(mol+)
rcN0(mol+)(sn) rcN0(mol+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN0(mol+)(sn)
rcN1 rcN1 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1
rcN1(f) rcN1(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1(f)
rcN1(sn) rcN1(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1(sn)
rcN1mi rcN1mi N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1mi
rcN1mi(f) rcN1mi(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1mi(f)
rcN1mi(sn) rcN1mi(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1mi(sn)
rcN1a rcN1a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1a
rcN1a(f) rcN1a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1a(f)
rcN1a(sn) rcN1a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1a(sn)
rcN1b rcN1b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1b
rcN1b(f) rcN1b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1b(f)
rcN1b(sn) rcN1b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1b(sn)
rcN1c rcN1c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1c
rcN1c(f) rcN1c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1c(f)
rcN1c(sn) rcN1c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN1c(sn)
rcN2 rcN2 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2
rcN2(f) rcN2(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2(f)
rcN2(sn) rcN2(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2(sn)
rcN2a rcN2a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2a
rcN2a(f) rcN2a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2a(f)
rcN2a(sn) rcN2a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2a(sn)
rcN2b rcN2b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2b
rcN2b(f) rcN2b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2b(f)
rcN2b(sn) rcN2b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2b(sn)
rcN2c rcN2c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2c
rcN2c(f) rcN2c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2c(f)
rcN2c(sn) rcN2c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN2c(sn)
rcN3 rcN3 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3
rcN3(f) rcN3(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3(f)
rcN3(sn) rcN3(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3(sn)
rcN3a rcN3a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3a
rcN3a(f) rcN3a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3a(f)
rcN3a(sn) rcN3a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3a(sn)
rcN3b rcN3b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3b
rcN3b(f) rcN3b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3b(f)
rcN3b(sn) rcN3b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3b(sn)
rcN3c rcN3c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3c
rcN3c(f) rcN3c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3c(f)
rcN3c(sn) rcN3c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rcN3c(sn)

Opm.: De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).

rcrpM_AfstandsMetastasenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.27 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
rcM0 rcM0 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM0
rcM0(i+) rcM0(i+) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM0(i+)
rcM0(mol+) rcM0(mol+) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM0(mol+)
rcM1 rcM1 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1
rcM1a rcM1a M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1a
rcM1a(0) rcM1a(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1a(0)
rcM1a(1) rcM1a(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1a(1)
rcM1b rcM1b M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1b
rcM1b(0) rcM1b(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1b(0)
rcM1b(1) rcM1b(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1b(1)
rcM1c rcM1c M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1c
rcM1c(0) rcM1c(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1c(0)
rcM1c(1) rcM1c(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1c(1)
rcM1d rcM1d M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1d
rcM1d(0) rcM1d(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1d(0)
rcM1d(1) rcM1d(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rcM1d(1)
rpM1 rpM1 M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1
rpM1a rpM1a M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1a
rpM1a(0) rpM1a(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1a(0)
rpM1a(1) rpM1a(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1a(1)
rpM1b rpM1b M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1b
rpM1b(0) rpM1b(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1b(0)
rpM1b(1) rpM1b(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1b(1)
rpM1c rpM1c M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1c
rpM1c(0) rpM1c(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1c(0)
rpM1c(1) rpM1c(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1c(1)
rpM1d rpM1d M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1d
rpM1d(0) rpM1d(0) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1d(0)
rpM1d(1) rpM1d(1) M_Afstandsmetastase 2.16.840.1.113883.2.4.3.11.60.40.4.10.3 rpM1d(1)

Opm.: De uitbreiding naar metastase op afstand (M) voor een klinische of postchirurgische histologische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).

rcT_PrimaireTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.13 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
rcTx rcTx T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTx
rcT0 rcT0 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT0
rcTa rcTa T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTa
rcTis rcTis T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTis
rcTis (DCIS) rcTis (DCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTis (DCIS)
rcTis (LAMN) rcTis (LAMN) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTis (LAMN)
rcTis (LCIS) rcTis (LCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTis (LCIS)
rcTis (Paget) rcTis (Paget) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTis (Paget)
rcTis pu rcTis pu T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcTis pu
rcT1 rcT1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1
rcT1mi rcT1mi T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1mi
rcT1a rcT1a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1a
rcT1a1 rcT1a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1a1
rcT1a2 rcT1a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1a2
rcT1b rcT1b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1b
rcT1b1 rcT1b1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1b1
rcT1b2 rcT1b2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1b2
rcT1c rcT1c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1c
rcT1c1 rcT1c1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1c1
rcT1c2 rcT1c2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1c2
rcT1c3 rcT1c3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1c3
rcT1d rcT1d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT1d
rcT2 rcT2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT2
rcT2a rcT2a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT2a
rcT2a1 rcT2a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT2a1
rcT2a2 rcT2a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT2a2
rcT2b rcT2b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT2b
rcT2c rcT2c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT2c
rcT2d rcT2d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT2d
rcT3 rcT3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT3
rcT3a rcT3a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT3a
rcT3b rcT3b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT3b
rcT3c rcT3c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT3c
rcT3d rcT3d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT3d
rcT3e rcT3e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT3e
rcT4 rcT4 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT4
rcT4a rcT4a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT4a
rcT4b rcT4b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT4b
rcT4c rcT4c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT4c
rcT4d rcT4d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT4d
rcT4e rcT4e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rcT4e

Opm.: De primaire tumor (T) voor een klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).

rpN_RegionaleLymfeklierenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.23 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
rpNX rpNX N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpNX
rpNX(f) rpNX(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpNX(f)
rpNX(sn) rpNX(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpNX(sn)
rpN0 rpN0 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0
rpN0(f) rpN0(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(f)
rpN0(sn) rpN0(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(sn)
rpN0(i-) rpN0(i-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(i-)
rpN0(i-)(sn) rpN0(i-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(i-)(sn)
rpN0(i+) rpN0(i+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(i+)
rpN0(i+)(sn) rpN0(i+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(i+)(sn)
rpN0(mol-) rpN0(mol-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(mol-)
rpN0(mol-)(sn) rpN0(mol-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(mol-)(sn)
rpN0(mol+) rpN0(mol+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(mol+)
rpN0(mol+)(sn) rpN0(mol+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN0(mol+)(sn)
rpN1 rpN1 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1
rpN1(f) rpN1(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1(f)
rpN1(sn) rpN1(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1(sn)
rpN1mi rpN1mi N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1mi
rpN1mi(f) rpN1mi(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1mi(f)
rpN1mi(sn) rpN1mi(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1mi(sn)
rpN1a rpN1a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1a
rpN1a(f) rpN1a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1a(f)
rpN1a(sn) rpN1a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1a(sn)
rpN1b rpN1b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1b
rpN1b(f) rpN1b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1b(f)
rpN1b(sn) rpN1b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1b(sn)
rpN1c rpN1c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1c
rpN1c(f) rpN1c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1c(f)
rpN1c(sn) rpN1c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN1c(sn)
rpN2 rpN2 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2
rpN2(f) rpN2(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2(f)
rpN2(sn) rpN2(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2(sn)
rpN2a rpN2a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2a
rpN2a(f) rpN2a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2a(f)
rpN2a(sn) rpN2a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2a(sn)
rpN2b rpN2b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2b
rpN2b(f) rpN2b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2b(f)
rpN2b(sn) rpN2b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2b(sn)
rpN2c rpN2c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2c
rpN2c(f) rpN2c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2c(f)
rpN2c(sn) rpN2c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN2c(sn)
rpN3 rpN3 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3
rpN3(f) rpN3(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3(f)
rpN3(sn) rpN3(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3(sn)
rpN3a rpN3a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3a
rpN3a(f) rpN3a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3a(f)
rpN3a(sn) rpN3a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3a(sn)
rpN3b rpN3b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3b
rpN3b(f) rpN3b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3b(f)
rpN3b(sn) rpN3b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3b(sn)
rpN3c rpN3c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3c
rpN3c(f) rpN3c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3c(f)
rpN3c(sn) rpN3c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 rpN3c(sn)

Opm.: De uitbreiding naar regionale lymfeklieren (N) voor een postchirurgische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).

rpT_PrimaireTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.14 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
rpTx rpTx T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTx
rpT0 rpT0 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT0
rpTa rpTa T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTa
rpTis rpTis T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTis
rpTis (DCIS) rpTis (DCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTis (DCIS)
rpTis (LAMN) rpTis (LAMN) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTis (LAMN)
rpTis (LCIS) rpTis (LCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTis (LCIS)
rpTis (Paget) rpTis (Paget) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTis (Paget)
rpTis pu rpTis pu T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpTis pu
rpT1 rpT1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1
rpT1mi rpT1mi T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1mi
rpT1a rpT1a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1a
rpT1a1 rpT1a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1a1
rpT1a2 rpT1a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1a2
rpT1b rpT1b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1b
rpT1b1 rpT1b1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1b1
rpT1b2 rpT1b2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1b2
rpT1c rpT1c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1c
rpT1c1 rpT1c1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1c1
rpT1c2 rpT1c2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1c2
rpT1c3 rpT1c3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1c3
rpT1d rpT1d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT1d
rpT2 rpT2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT2
rpT2a rpT2a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT2a
rpT2a1 rpT2a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT2a1
rpT2a2 rpT2a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT2a2
rpT2b rpT2b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT2b
rpT2c rpT2c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT2c
rpT2d rpT2d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT2d
rpT3 rpT3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT3
rpT3a rpT3a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT3a
rpT3b rpT3b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT3b
rpT3c rpT3c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT3c
rpT3d rpT3d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT3d
rpT4 rpT4 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT4
rpT4a rpT4a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT4a
rpT4b rpT4b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT4b
rpT4c rpT4c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT4c
rpT4d rpT4d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT4d
rpT4e rpT4e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 rpT4e

Opm.: De primaire tumor (T) voor een post chirurgische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).

TNMVersieCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.6 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
AJCC 1ste editie AJCCTNM1 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 1ste editie
AJCC 2e editie AJCCTNM2 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 2e editie
AJCC 3e editie AJCCTNM3 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 3e editie
AJCC 4e editie AJCCTNM4 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 4e editie
AJCC 5e editie AJCCTNM5 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 5e editie
AJCC 6e editie AJCCTNM6 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 6e editie
AJCC 7e editie AJCCTNM7 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 7e editie
AJCC 8e editie AJCCTNM8 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 8e editie
AJCC 9e editie AJCCTNM9 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 AJCC TNM 9e editie
UICC 1ste editie UICCTNM1 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 1ste editie
UICC 2e editie UICCTNM2 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 2e editie
UICC 3e editie UICCTNM3 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 3e editie
UICC 4e editie UICCTNM4 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 4e editie
UICC 5e editie UICCTNM5 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 5e editie
UICC 6e editie UICCTNM6 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 6e editie
UICC 7e editie UICCTNM7 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 7e editie
UICC 8e editie UICCTNM8 TNMVersie 2.16.840.1.113883.2.4.3.11.60.40.4.10.8 UICC TNM 8e editie

V_VeneuzeInvasieCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.7 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
VX VX V_VeneuzeInvasie 2.16.840.1.113883.2.4.3.11.60.40.5.1.4 Aanwezigheid van veneuze invasie kan niet beoordeeld worden
V0 V0 V_VeneuzeInvasie 2.16.840.1.113883.2.4.3.11.60.40.5.1.4 Geen veneuze invasie
V1 V1 V_VeneuzeInvasie 2.16.840.1.113883.2.4.3.11.60.40.5.1.4 Microscopische veneuze invasie
V2 V2 V_VeneuzeInvasie 2.16.840.1.113883.2.4.3.11.60.40.5.1.4 Macroscopische veneuze invasie

ycN_RegionaleLymfeklierenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.19 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
ycNX ycNX N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycNX
ycNX(f) ycNX(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycNX(f)
ycNX(sn) ycNX(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycNX(sn)
ycN0 ycN0 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0
ycN0(f) ycN0(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(f)
ycN0(sn) ycN0(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(sn)
ycN0(i-) ycN0(i-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(i-)
ycN0(i-)(sn) ycN0(i-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(i-)(sn)
ycN0(i+) ycN0(i+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(i+)
ycN0(i+)(sn) ycN0(i+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(i+)(sn)
ycN0(mol-) ycN0(mol-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(mol-)
ycN0(mol-)(sn) ycN0(mol-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(mol-)(sn)
ycN0(mol+) ycN0(mol+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(mol+)
ycN0(mol+)(sn) ycN0(mol+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN0(mol+)(sn)
ycN1 ycN1 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1
ycN1(f) ycN1(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1(f)
ycN1(sn) ycN1(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1(sn)
ycN1mi ycN1mi N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1mi
ycN1mi(f) ycN1mi(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1mi(f)
ycN1mi(sn) ycN1mi(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1mi(sn)
ycN1a ycN1a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1a
ycN1a(f) ycN1a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1a(f)
ycN1a(sn) ycN1a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1a(sn)
ycN1b ycN1b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1b
ycN1b(f) ycN1b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1b(f)
ycN1b(sn) ycN1b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1b(sn)
ycN1c ycN1c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1c
ycN1c(f) ycN1c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1c(f)
ycN1c(sn) ycN1c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN1c(sn)
ycN2 ycN2 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2
ycN2(f) ycN2(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2(f)
ycN2(sn) ycN2(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2(sn)
ycN2a ycN2a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2a
ycN2a(f) ycN2a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2a(f)
ycN2a(sn) ycN2a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2a(sn)
ycN2b ycN2b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2b
ycN2b(f) ycN2b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2b(f)
ycN2b(sn) ycN2b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2b(sn)
ycN2c ycN2c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2c
ycN2c(f) ycN2c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2c(f)
ycN2c(sn) ycN2c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN2c(sn)
ycN3 ycN3 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3
ycN3(f) ycN3(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3(f)
ycN3(sn) ycN3(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3(sn)
ycN3a ycN3a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3a
ycN3a(f) ycN3a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3a(f)
ycN3a(sn) ycN3a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3a(sn)
ycN3b ycN3b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3b
ycN3b(f) ycN3b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3b(f)
ycN3b(sn) ycN3b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3b(sn)
ycN3c ycN3c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3c
ycN3c(f) ycN3c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3c(f)
ycN3c(sn) ycN3c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ycN3c(sn)

Opm.: De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).

ycT_PrimaireTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.10 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
ycTx ycTx T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTx
ycT0 ycT0 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT0
ycTa ycTa T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTa
ycTis ycTis T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTis
ycTis (DCIS) ycTis (DCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTis (DCIS)
ycTis (LAMN) ycTis (LAMN) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTis (LAMN)
ycTis (LCIS) ycTis (LCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTis (LCIS)
ycTis (Paget) ycTis (Paget) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTis (Paget)
ycTis pu ycTis pu T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycTis pu
ycT1 ycT1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1
ycT1mi ycT1mi T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1mi
ycT1a ycT1a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1a
ycT1a1 ycT1a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1a1
ycT1a2 ycT1a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1a2
ycT1b ycT1b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1b
ycT1b1 ycT1b1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1b1
ycT1b2 ycT1b2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1b2
ycT1c ycT1c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1c
ycT1c1 ycT1c1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1c1
ycT1c2 ycT1c2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1c2
ycT1c3 ycT1c3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1c3
ycT1d ycT1d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT1d
ycT2 ycT2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT2
ycT2a ycT2a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT2a
ycT2a1 ycT2a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT2a1
ycT2a2 ycT2a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT2a2
ycT2b ycT2b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT2b
ycT2c ycT2c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT2c
ycT2d ycT2d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT2d
ycT3 ycT3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT3
ycT3a ycT3a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT3a
ycT3b ycT3b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT3b
ycT3c ycT3c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT3c
ycT3d ycT3d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT3d
ycT3e ycT3e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT3e
ycT4 ycT4 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT4
ycT4a ycT4a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT4a
ycT4b ycT4b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT4b
ycT4c ycT4c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT4c
ycT4d ycT4d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT4d
ycT4e ycT4e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ycT4e

Opm.: De primaire tumor (T) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).

ypN_RegionaleLymfeklierenCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.21 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
ypNX ypNX N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypNX
ypNX(f) ypNX(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypNX(f)
ypNX(sn) ypNX(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypNX(sn)
ypN0 ypN0 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0
ypN0(f) ypN0(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(f)
ypN0(sn) ypN0(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(sn)
ypN0(i-) ypN0(i-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(i-)
ypN0(i-)(sn) ypN0(i-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(i-)(sn)
ypN0(i+) ypN0(i+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(i+)
ypN0(i+)(sn) ypN0(i+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(i+)(sn)
ypN0(mol-) ypN0(mol-) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(mol-)
ypN0(mol-)(sn) ypN0(mol-)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(mol-)(sn)
ypN0(mol+) ypN0(mol+) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(mol+)
ypN0(mol+)(sn) ypN0(mol+)(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN0(mol+)(sn)
ypN1 ypN1 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1
ypN1(f) ypN1(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1(f)
ypN1(sn) ypN1(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1(sn)
ypN1mi ypN1mi N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1mi
ypN1mi(f) ypN1mi(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1mi(f)
ypN1mi(sn) ypN1mi(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1mi(sn)
ypN1a ypN1a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1a
ypN1a(f) ypN1a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1a(f)
ypN1a(sn) ypN1a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1a(sn)
ypN1b ypN1b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1b
ypN1b(f) ypN1b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1b(f)
ypN1b(sn) ypN1b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1b(sn)
ypN1c ypN1c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1c
ypN1c(f) ypN1c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1c(f)
ypN1c(sn) ypN1c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN1c(sn)
ypN2 ypN2 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2
ypN2(f) ypN2(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2(f)
ypN2(sn) ypN2(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2(sn)
ypN2a ypN2a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2a
ypN2a(f) ypN2a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2a(f)
ypN2a(sn) ypN2a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2a(sn)
ypN2b ypN2b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2b
ypN2b(f) ypN2b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2b(f)
ypN2b(sn) ypN2b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2b(sn)
ypN2c ypN2c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2c
ypN2c(f) ypN2c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2c(f)
ypN2c(sn) ypN2c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN2c(sn)
ypN3 ypN3 N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3
ypN3(f) ypN3(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3(f)
ypN3(sn) ypN3(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3(sn)
ypN3a ypN3a N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3a
ypN3a(f) ypN3a(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3a(f)
ypN3a(sn) ypN3a(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3a(sn)
ypN3b ypN3b N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3b
ypN3b(f) ypN3b(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3b(f)
ypN3b(sn) ypN3b(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3b(sn)
ypN3c ypN3c N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3c
ypN3c(f) ypN3c(f) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3c(f)
ypN3c(sn) ypN3c(sn) N_RegionaleLymfeklieren 2.16.840.1.113883.2.4.3.11.60.40.4.10.11 ypN3c(sn)

Opm.: De uitbreiding naar regionale lymfeklieren (N) voor een classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).

ypT_PrimaireTumorCodelijst

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.12 Binding: Extensible
Conceptnaam Conceptcode Codestelselnaam Codesysteem OID Omschrijving
ypTx ypTx T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTx
ypT0 ypT0 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT0
ypTa ypTa T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTa
ypTis ypTis T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTis
ypTis (DCIS) ypTis (DCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTis (DCIS)
ypTis (LAMN) ypTis (LAMN) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTis (LAMN)
ypTis (LCIS) ypTis (LCIS) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTis (LCIS)
ypTis (Paget) ypTis (Paget) T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTis (Paget)
ypTis pu ypTis pu T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypTis pu
ypT1 ypT1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1
ypT1mi ypT1mi T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1mi
ypT1a ypT1a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1a
ypT1a1 ypT1a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1a1
ypT1a2 ypT1a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1a2
ypT1b ypT1b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1b
ypT1b1 ypT1b1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1b1
ypT1b2 ypT1b2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1b2
ypT1c ypT1c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1c
ypT1c1 ypT1c1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1c1
ypT1c2 ypT1c2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1c2
ypT1c3 ypT1c3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1c3
ypT1d ypT1d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT1d
ypT2 ypT2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT2
ypT2a ypT2a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT2a
ypT2a1 ypT2a1 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT2a1
ypT2a2 ypT2a2 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT2a2
ypT2b ypT2b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT2b
ypT2c ypT2c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT2c
ypT2d ypT2d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT2d
ypT3 ypT3 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT3
ypT3a ypT3a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT3a
ypT3b ypT3b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT3b
ypT3c ypT3c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT3c
ypT3d ypT3d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT3d
ypT4 ypT4 T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT4
ypT4a ypT4a T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT4a
ypT4b ypT4b T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT4b
ypT4c ypT4c T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT4c
ypT4d ypT4d T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT4d
ypT4e ypT4e T_PrimaireTumor 2.16.840.1.113883.2.4.3.11.60.40.4.10.10 ypT4e

Opm.: De primaire tumor (T) voor een classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).

Deze bouwsteen in overige publicaties

Bouwsteen verwijzingen

Deze bouwsteen verwijst naar

Deze bouwsteen wordt gebruikt in

--

Technische specificaties in HL7v3 CDA en HL7 FHIR

Om informatie op basis van zorginformatiebouwstenen uit te wisselen zijn aanvullende, meer technische specificaties nodig.
Niet iedere omgeving kan met dezelfde technische specificaties overweg. Om deze reden zijn er meerdere typen technische specificaties:

  • HL7® versie 3 CDA compatibele specificaties, beschikbaar via de Nictiz ART-DECOR® omgeving Artdecor.jpg
  • HL7® FHIR® compatibele specificaties, beschikbaar via de Nictiz-omgeving op de Simplifier FHIR Registry Fhir.png

Downloads

De bouwsteen is ook beschikbaar als pdf bestand PDF.png of als spreadsheet Xlsx.png

Over deze informatie

De informatie in deze wiki pagina is gebaseerd op de Publicatie 2020
SNOMED CT en LOINC codes zijn gebaseeerd op:

  • SNOMED Clinical Terms version: 20200731 [R] (July 2020 Release)
  • LOINC version 2.67

De voorwaarden van gebruik staan op de beginpagina List2.png
Deze pagina is gegenereerd op 29/09/2020 22:35:00 met ZibExtraction v. 4.0.7577.31095

Back 16.png Terug naar ZIB overzicht
Overgenomen van "https://zibs.test-nictiz.nl/index.php?title=TNMTumorClassificatie-v1.0(2020NL)&oldid=21896"